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                                          1. INTRODUCTION 
Cancer is characterized by never-ending and uncontrolled anarchic cell 
proliferation. This anarchic proliferation of abnormal cells is opposed to the 
controlled, harmonious proliferation of normal tissues which only occurs to repair 
damaged or worn tissues. Carcinogenic factors (tobacco, alcohol, pollutants, 
chemicals, radioactivity, vaccines, viruses, aging, stress, violence, despair, etc.) 
produce mutations or methylations.  
Cancer is the second leading cause of clinical mortality in developed 
countries. Cancer and tumors are the result of altered, excessive and invasive cell 
reproduction in other nearby healthy tissues, their development can be originated from 
diverse causes, like genetics, to the consumption of potentially toxic and harmful 
foods. In India, tumors (neoplasms) are the third cause of mortality. In this category, 
malignant tumors of the cervix are the first cause of female death. Cervical cancer is 
the second most common cancer in the women worldwide and the leading cause of 
cancer deaths among women in developing countries
(1)
.  
            Sexually transmitted human papilloma virus (HPV) infection is the most 
important risk factor for cervical intraepithelial neoplasm and invasive cervical 
cancer
(2)
.HPV serotypes 16 and 18 account for nearly 76.7% of cervical cancer in 
India. Warts have been reported in 2–25% of sexually transmitted disease clinic 
attendees in India; however, there is no data on the burden of anogenital warts in the 
general community
(3)
. 
Every year in India, 122,844 women are diagnosed with cervical cancer and 
67,477 die from the disease
(4)
. 
HPV is a virus that can lead to conditions as harmless as a wart and as deadly 
as cervical cancer. Although there is no cure for HPV, there are preventative measures 
and herbs with antiviral properties that might be able to reduce the adverse effects and 
spread of the disease. Human papilloma virus (HPV) is a virus that can infect human 
mucous membranes and epidermis, which can lead to cancers of the vagina, anus, 
cervix, vulva and penis. There are more than 100 different types that are usually 
divided into those that cause warts, those that cause cancer, and those that have no 
symptoms at all (which are essentially harmless). Some types of viruses can be 
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sexually treated (like the strain that causes genital warts) and some have a chance to 
get rid of on their own within two years of 90 percent. The Pap smear test is intended 
to detect the cells that can develop in the cervix of the uterus as a result of HPV. 
In Modern system of medicine, the main strategy of treating patients with 
cancer are surgery, radiation and chemotherapy
(5)
. Most patients unfortunately seek 
Siddha system of medicine or other traditional systems of medicine after a failure of 
chemotherapy and very aggravated situation most of the time.In Siddha system of 
medicine, plants, metals and mineral based medicines have been used since ancient 
times to treat and prevent different types of cancer.  
Cancer and tumors, whether benign or malignant, are a condition that can be 
treated with Siddha medicines, either in combination with other treatments or even 
medicines, as the Siddha medicine does not interfere with any other anti-cancer 
alternative and can certainly support the patient in a positive way in the healing 
process. 
In this regard, effective therapy against cancer, thousands of research on plants 
and other metallo- mineral preparations from Siddha system of medicine to find 
potent anti-cancer agents.These medicine have treated many diseases across all over 
India for thousands of years including cancer. They slow down or block cancer 
proliferation and stimulate the body's anti-cancer defenses.      
In Siddha treatment, there are number of medicines to cure cervical cancer in a 
non-complicated way. There are also number of literature works to facilitate this. In 
particular, a potent medicine “RASAPARPAM” is mentioned in the classical Siddha 
book “ Aathma Rakshamirtham Ennum Vaithiya Saara Sangiragam” written by 
Kandhasamy Mudhaliyar. 
Mercury: 
           In Siddha medicine, mercury is extensively used in the preparation of 
medicines after purification. Mercury is also used to in the alchemical and 
rejuvenation medicine preparations. 
           RASA means elixir of life and the word is attributed to the most important 
factor responsible for life in various fields of life of knowledge. In the herbal domain 
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it is the essence of a substance. The same meaning is implied to mercury by denoting 
it as rasa (ரச) of the mineral kingdom, or in other words the metal of utmost 
important having distinct properties and unique nature is given the term “Rasa”(6) 
 
 Even though pure herbal based medicines are effective, mercury based 
medicines like Parpam, Mezhugu and Chendhooram are prepared for the following 
reasons
 (7)
 
 Highly potent 
 Fast action 
 Vast utility 
 Easy to consume 
 Smaller dose is enough 
 Acts as rejuvenation medicine 
              Mercury is the most superior among the other metals. Mercury is compared 
to lord Siva because it has 
(8) (9)
 
 Creative power 
 Protective power 
 Destructive power 
PARPAM 
               In  Siddha,  Parpam is considered as a higher order of medicine. Even a 
small dose of Parpam can used to cure  chronic diseases, complicated diseases and 
life threatening diseases like cancer etc.,  
The most super natural power present in Parpam is its longevity, it has a longevity of 
100 years.  
The peculiarities of  Parpam and its significance are expressed by Theran in his words 
are as follows
(10)
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“ வரீத்து நிக்கவவ ஧ற்஧ங்களள- ஧ரி 
காரத்து நிக்கவவ ஧ற்஧ங்களள 
 ஧ாருக்குள் நா஦ிடர் ள஥ாய்ள஧ாக- வரு 
஧ண்டிதருக்ககல்லா நாளநாகம் 
 வரீகடாரி – ஧ிணிக்ககாரு 
஧ாரகுடாரி – விவசக஧று 
 தீரதடாரி – விவ஦யுடு 
சூரிக்குழு ள஥கராத்தது 
 ளநருக்கிவ஦ ஧ாரப்புறம். “                              
- ளதரன் தரு. 
       
           This Herbo mineral classical Siddha drug Rasaparpam is the best drug against 
cervical cancer. The present study was carried out with the objective of validating the 
safety and efficacy of Rasaparpam and its potent cytotoxic activity in culture of HeLa 
and SiHa cells.  
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      2. AIM AND OBJECTIVE 
  
AIM: 
To justify the ancient Siddha drug for management of cervical cancer with its 
ultimate formulation and give good progress to the people affected by cevical cancer. 
The purpose of the present study was aimed to validate the activity of Rasa Parpam 
for its efficacy in managing Cervical cancer through pre-clinical aspects. 
 In the present medical world, there is a need for proper treatment for Cervical 
Cancer. The aim of this study is validation of a new drug for the management of 
Cervical cancer. 
 
OBJECTIVES 
     The key objectives of the study are, 
 Having a collective review of the literature. 
 Preparing the drug according to Siddha classical text. 
 Subjecting the drug to physico-chemical standardization. 
 Analyzing the drug chemically for detection of acid and basic radicals. 
 Focusing the drug for analytical assessment. 
 Studying the toxicity profile (acute and 28-days repeated  oral toxicity) of 
Rasa Parpam according to OECD guidelines. 
 Determining the pharmacological activity (In-vitro Anti-cancer activity) of 
Rasa Parpam.like, 
 
 Anti-cancer activity in HeLa cell line model by MTT 
assay, 
 Anti –tumor activity in HeLa and SiHa cell line models, 
 Anti- oxidant activity by DPPH assay. 
 
 Analyzing all the above study results to validate the benefits of Rasa Parpam . 
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           3. REVIEW OF LITERATURE 
 
3.1. Drug Review 
                                          3.1.1. Siddha Aspect  
1.  Rasam 
Synonyms 
Mercury or  Quick Silver 
Chemical name 
Hydragyrum 
Mercury (Rasam) comes under the classification of Pancha Sootham. The term „ 
Pancha Soothaas‟ refer the five types of  Mercury (Rasam). It has many connotations 
such has Sootham, Punniyam, Karpam, Satthu, Bharatham, Easan, Pootham 
according to “Dasanga Nigandu”. 
Mercury is obtained from its ores in countries like Spain, California, Russia, China 
and Japan. It is separated from its ore Cinnabar. 
Agonist to Mercury: 
Abragam         –  Mica 
Kaareeyam   –  Lead 
Kandhagam  –  Sulfur 
Velli              –  Silver 
Sembu           –  Copper 
Thuttham      –  Zinc 
Thalagam     –  Arsenic pentasulphide 
Veeram        –  Perchloride of Mercury 
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Antagonist : 
Singi                  –  Plumbioxidum 
Vellaipadanam -  White Arsenic 
Irumbu             –  Iron 
Kaantham        –  Magnet 
Soodan             –  Camphor 
Pooram           –  Sub chloride of Mercury 
Nimilai            –  Bismuth 
Pooneeru        –  Fuller’s earth 
 
Classification of Mercury 
It is classified into 5 types. It is made up of five basic elements and is classified into 5 
types according to the basic elemental ratio. 
1. Rasam  –  It is red in colour and without any ill effects 
2. Rasendhiran –This is black in colour  
3. Sootham  – This is yellow in colour contains impurities. Hence it should 
be purified and  detoxified before use.  
4. Misaragam – It is multicoloured. This also needs to be purified and 
detoxified before use. 
5. Bharatham – It is white in colour and found in commercial grades 
commonly. 
Mercury has the following properties 
Action: 
Vitalizer, Tonic, Laxative, Diuretic, Neutralises bile,Silagogue, Anti-inflammatory, 
cures venereal diseases (Meganasini). 
Taste: 
Six tastes – dominated by sweet 
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Potency: 
Hot and cold (both specialities) 
Further it facilitates to attain the following eight folded “ Siddhis” (Attama Siddhi) 
Anima, Mahima, Karima, Lahima, Prapthi, Prakamiyam, Esatthuvam, Vasithuvam. 
Dhosas ( Impurities) of Mercury: 
It has 2 types of  impurities, 
1. Dhosa 
2. Sattai 
Dhosa:  
There are 8 types of impurities in Mercury which cause various diseases are as 
follows, 
1. Undeenam       –  Throbbing pain (Soolai) 
2. Kowdilyam      –  disease of head (Kapaalanoi) 
3. Anavartham     –  Maniac illness (Brammai) 
4. Sangaram        –  Spermatorrhoea ( Thathunattam) 
5. Sandathavam  – Distress 
6. Panguthuvam  – Morbid thirst and leprosy 
7. Samalathvam   – Fever and syncope 
8. Savishathvam   – Emaciation – loss of weight 
Sattai: 
 7types 
1. Naagam   –  Piles 
2. Vangam   –  Skin disease 
3. Malam     –  Ignorance 
4. Vidam     –  Death  
5. Agni        –  Morbid thirst polydypsia 
6. Giri         –  Distress 
7. Sagalam  –  Spermatorrhoea 
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8 types of Dhosas and diseases according to Therayar, 
1. Sarppam    –  Blister 
2. Vangam      –  Skin diseases 
3. Ganthi        –  Heat  
4. Vanni         –  Burning sensation 
5. Sanjalam   –  Discolouration 
6. Malam       –  Spermatorrhoea 
7. Kaalam     –  Death 
8. Mantham  –  Syncope 
7 types of Dhosas and diseases according to Agathiyar, 
1. Nagam        –  Bad odour 
2. Vangam      –  Skin diseases 
3. Ganthi        –  Thirst 
4. Vanni         –  Spermatorrhoea 
5. Sanjalam    –  Death  
6. Vidamum   –  Toxic disease 
7. Logam       –  Aphrodisiac 
General characters of Mercury: 
“யிமிந஥ோய் கிபந்திகுன்நம் மநய்சூல஬ புண்குட் 
 டமிகோ஬ில் யிந்துயி஦ோல் அத்லத - யமினோய் 
 புரிம௃ யிதி னோது புரினிந஦ோ மனல்஬ோம் 
 இரிம௃யிதி னோது நில்ல஬ ” 
        - குண஧ோடம் தோது-சீய யகுப்பு 
 
Proper use of Mercury as a medicine  cures the following diseases. They are disease 
of eyes, syphilis, eight types of peptic ulcers (gunmam), throbbing pain (soolai), 
chronic ulcers (perumpun), leprosy ( Hansen‟s disease). 
2 types of properties: 
1. Beneficial properties 
2. Harmful effects 
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Beneficial properties: 
 It purifies blood 
 It improves quality of blood and semen 
 Stimulates appetite 
 Kills the micro-organisms and cures the wound. 
 It cures the diseases of internal and external organs of the body 
 It improves memory power, cures Amnesia 
 It strengthens the nerve plexuses 
 It develops wisdom through concentration of mind 
 It prevents senility and increases the life span. 
Harmful effects: 
Unpurified Mercury causes, 
 Bleeding  
 Dropsy 
 Anaemia 
 Excessive body heat 
 Sweating 
  Diarrhea  
 Thirst  
 Flatulence 
  Blabbering  
  Skin diseases 
 Burning sensation of the limbs 
 Diseases of head 
 Fever  
 Shivering 
 Hiccough etc., 
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Purification and detoxification of Mercury: 
Mercury                       -  35grams 
Brick powder              -  Required quantity 
Turmeric powder        -   Required quantity 
Acalyphaindica juice  -   1.3 lit 
Mercury was triturated with finely powdered brick and then turmeric powder for one 
hour respectively and washed with water. Then Mercury is boiled with the juice of 
Acalypha indica till the juice completely evaporates. We get purified Mercury. 
Some  preparations of Mercury: 
 Soothakaruppu 
 Rasa mezhugu 
 Rasa thailam 
 Megaviranakalimbu 
 Rasa kuligai 
Antidotes for Mercurial poisoning: 
 If the Mercurial poison affects the gluteal region, root bark of dye plant 
(Caesalpiniasappan-Sayapattai) is powdered and given along with jaggery.  
 When teeth are affected  the stem juice of ivy gourd (Coccinaindica- kovai) 
may be squeezed on the tongue. 
 If there is burning sensation in limbs, urticaria, dryness of the throat and the 
patient is unconscious, Barmuda grass root stalk ( Cynodondactylon- 
Aruganizhangu) is triturated and dissolved in goat‟s milk or cow‟s milk or 
butter milk or cotton seed milk is filtered and administered
(11)
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3.1.2. Modern Aspect 
 
Mercury 
Mercury is not less than 99.5 percent of Hg. It occurs naturally as a Sulphide ore 
called Cinnabar HgS. It also occurs in small globules disseminated through rocks and 
as amalgam of Silver and Gold. 
Chemical properties of Mercury (12) 
 
 
 
 
 
 
 
 
 
 
 
Preparation: 
  It is obtained by roasting Cinnabar in a current of air HgS+O2→Hg+SO2 
 The free Mercury gets liberated. It may be either purified by volatilization or 
chemically by dropping Mercury into a column of dilute Nitric acid for 
removing basic impurities. 
Properties:   
It is shiny silvery white in nature. Heavy liquid easily divisible into globules 
and extremely mobile, easily volatilizes on heating. It boils at 359.58°C. 
Atomic number - 80    
Atomic mass - 200.59g.mol
-1 
  
 
Electro negativity - 1.9    
Density - 13.6g.cm
-3
 at 20
º
c    
Melting point - -38.9ºc    
Boiling point - 356.6
º
c    
Radius - 0.157nm    
Ionic radius - 0.11nm (+2)    
Isotopes - 12    
Electronic shell - [Xe]4f
14 
   
Standard potential - +0.854V    
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Almost insoluble in water, alcohol and HCl. It dissolves in cold and dilute Nitric acid, 
giving Mercurial nitrate and Nitric oxide
(13)
. 
                     6Hg+8HNO3→ 3Hg2 (NO3)2+2NO+4H2O 
Mercury salts   
           The most important Mercury salts are Mercuric chloride HgCl2 (corrosive 
sublimate - a violent poison), Mercurous chloride Hg2Cl2 (Calomel, still used in 
medicine occasionally), Mercury fulminate (Hg (ONC)2, a detonator used in 
explosives) and Mercuric sulphide (HgS, Vermillion, a high-grade paint pigment) 
Applications 
(14) 
 Mercury as a metal has many uses. Because of its high density it is used in 
barometers and manometers. It is extensively used in thermometers, due to its 
high rate of thermal expansion that is fairly constant over a wide temperature 
range. 
  Its ease in amalgamating with gold is used in the recovery of gold from its 
ores. 
 Industry uses Mercury metal as a liquid electrode in the manufacture of 
chlorine and Sodium hydroxide by electrolysis of brine.  
 Mercury is still used in some electrical gear, such as switches and rectifiers, 
which need to be reliable, and for industrial catalysis.  
 Much less Mercuryis  now used in consumer batteries and fluorescent lighting, 
but it has not been entirely eliminated.  
 Mercury compounds have many uses. Calomel (Mercurous chloride, Hg2Cl2) 
is used as a standard in electrochemical measurements and in  medicine as a 
purgative. 
  Mercuric chloride (corrosive sublimate, HgCl2) is used as an insecticide, in rat 
poison, and as a disinfectant.  
 Mercuric oxide is used in skin ointments.  
 Mercuric sulphate is used as a catalyst in organic chemistry.  
 Vermilion, a red pigment, is mercuric sulphide; another crystalline form of the 
Sulphide (also used as a pigment) is black. 
  Mercury fulminate Hg (CNO) 2 is used as a detonator. 
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Mercurial preparations: 
 Mercury with Chalk (Grew powder) 
 Yellow Mercuric Oxide (HgO) 
 Mercuric Oxide 
 Oleated Mercury 
 Mercurous Chloride (HgCl-Calomel) 
Tests for Purity: 
It has been tested for weight per ml (at 25°C is about 13.5g).Non-volatile matter 
residue at 300°C (not more than 0.02℅w/w). 
Assay:  
An accurately weighed quantity (0.49g) is dissolved in equal parts (20ml) of water 
and Nitric acid. It is heated gently until the solution becomes colourless. The solution 
is then diluted with water (150ml) and sufficient quantity of Potassium permanganate 
is added till a permanent pink colour is obtained. A trace of ferrous sulphate to 
discharge pink colour is added. Then the solution is titrated with standard 0.1N 
Ammonium thiocyanate (1ml of 0.1N Ammonium thiocyanate =0.01003g), using 
Ferric Ammonium sulphate as indicator. The temperature during the titration should 
not exceed above 20°C. 
3Hg+8HNO3→3Hg (NO8)2+4H20+2NO↑ 
Hg (NO3)2+2NH4SCN→2NH4NO3+Hg (SCN)2 
                                             
                                         
                                            Fig.No.1. ELEMENTAL MERCURY 
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Uses 
It is a pharmaceutical aid and for preparing Mercury with chalk .Formerly metallic 
Mercury was used therapeutically as a cathartic and parasticide. Almost all the salts of 
Mercury with the exception of the Sulphide is poisonous. 
1. Mercury with chalk (Grew powder) 
 It is having 31 -35℅ w/w of Mercury and 62-70℅ w/w of CaCO3 
 It is used as a purgative (Dose 60-300mg) 
2. Yellow mercuric Oxide (HgO) 
 It has not less than 99.5℅ HgO. It is used as a mild anti-septic, anti-
infective and anti- bacterial agent. 
3.  Mercuric Oxide: 
 It contains not less than 95℅ but not more than105℅ w/w of the stated 
amount of yellow Mercuric oxide 
 It is used in ophthalmology, 1℅ ointment to treat mild inflammatory 
conditions for the treatment of blepharitis and conjunctivitis. 
4. OleatedMercury: 
 It has the equivalent of 20℅ of yellow Mercuric oxide 
 It is used as an anti-infective. 
 
5. Mercuric chloride (HgCl - Calomel): 
 It is  not less than 99.6℅ of HgCl 
 It has been used for centuries as a cathartic but recently it is replaced 
by other drugs 
(15)
.  
Calomel is insoluble in gastric juice and is not absorbed from the stomach. It gets 
absorbed in the intestine by the alkaline pancreatic juice where it slowly gets 
dissociated into Mercury and irritant Mercuric compounds which  exerts  a cathartic 
action
(16)
. 
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                                                   Siddha Aspect  
2. Gandhagam (Sulfur)   
Chemical name 
Sulfur  
Synonyms  
Kaarizhainnaatham, Paraiveeriam, Atheethaprakaasam, Peejam, Sakthi, 
Sakthipeesam, Selvivindhu, Naatham, Naatram, Deviuram. 
General properties  
Taste: 
Gandhagam is bitter and astringent in taste. 
Actions: 
 Laxative 
 Tonic  
 Antiseptic  
 It increases the various secretions of the body including skin. When used in high 
doses, it causes diarrhea. 
Types 
Gandhagamis divided into four types depending upon their colour, appearance and 
properties. 
           1. White colored Sulfur 
           2. Red colored Sulfur 
           3. Golden yellow colored Sulfur 
           4. Black colored Sulfur. 
In addition, gooseberry Sulfur and stick Sulfur (Vaanagandhagam) have been 
mentioned in most of the text books of ancient Siddha medicines. Gooseberry Sulfur 
is  often used in medicinal preparations. 
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General characters of Gooseberry Sulfur (Nellikai gandhagam)  
      “ம஥ல்஬ிக்கோய்க் கந்திக்கு ஥ீள்஧திம஦ண் குட்டநந்தம் 
யல்ல஬ கயிலசகுன்ந யோம௃கண்நணோய் – ம஧ோல்஬ோ 
யிடக்கடியன் நநகந஥ோய் யறீுசுபம் ந஧தி 
திடக்கிபக ணகீ஧ம்ந஧ோந் நதர்”   
                                 - ஧தோர்த்த குண சிந்தோநணி. 
 
It is used in the treatment of 18 types of skin diseases, liver enlargement, abdominal 
distension, eye diseases, chronic venereal diseases, chronic diarrhea, gastric ulcer, 
poisonous bites, fever, and chronic dysentery. 
Method of purification 
Sulfur is placed in an Iron spoon. A small quantity of cow‟s butter is added and the 
spoon is heated till the butter melts, this mixture is poured in inclined position in 
cow‟s milk. This procedure is repeated for 30 times to get purified Sulfur. Each time 
fresh milk is to be used
(17)
.  
Preparations of Sulfur 
 Kandhagaparpam 
 Sarvavidathodarikuligai 
 Kandhagachendhooram 
 KandhagaMezhugu 
 KandhagaMaathirai 
 Kandhaga Thylam 
 Kandhaga Vadagam 
 Kandhaga Rasayanam 
                                               
                                              3.1.2. Modern Aspect  
Sulfur 
Sulphur or Sulfur is a Greek word which means “to burn”. Sulfur is a chemical 
element with the symbol S. It is a plentiful, multivalent non-metal. It occurs in nature 
as the pure element and as Sulfide and Sulfate minerals. Sulfur is referred to in the 
Bible as brimstone (burn stone) in English. 
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History: 
 Sulfur was discovered by Chinese before 2000BC and is recognized as an 
element by Antoine Lavoisier in 1777. 
 Sulfur is mentioned  in  Bible and was best known for destroying Sodom and 
Gomorrah. It was also known to the ancient Greeks and burnt as a fumigant. 
Sulfur was mined near Mount Etna in Sicily used for bleaching cloth and 
preserving wine, both of which involved burning it to form Sulfur dioxide and 
allowing this to be absorbed by wet clothes or the grape juice. For centuries, 
sulfur along with Mercury and salt, was believed to be a component of all 
metals and formed the basis of alchemy whereby one metal could be 
transmuted into another. 
 Antoine Lavoisier thought that Sulfur was an element, but in 1808 Humphry 
Davy said it contained hydrogen 
(18)
. 
 
Properties 
(19)
 
General properties: 
Symbol               -   S 
Number                -    16 
Element category        -    polyatomic nonmetal 
Physical properties:  
Phase      -   solid 
Density     -    1.96 g·cm−3 
Liquid density at M.P -   1.819 g·cm−3 
Heat of fusion     -     1.727 kJ·mol−1 
Heat of vaporization   -   45 kJ·mol−1 
Molar heat capacity   -    22.75 J·mol−1·K−1 
Electronegativity  -  2.58 (Pauling scale) 
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Chemical properties: 
Solubility     -    insoluble in water 
Vanderwaals radius      -   0.127 nm 
Ionic radius      -   0.184 (-2) nm; 0.029 (+6) 
Isotopes     -   5 
Electronic shell    -   [Ne] 3s23p4 
Standard potential    -   0.51 V 
Image explanation 
 The alchemical symbol for sulfur is shown against a „fire and brimstone‟ 
background. 
Appearance 
 There are several allotropes of sulfur. The most common appears as yellow 
crystals or powder. 
                                                
                                                     Fig.No.2.  Sulfur 
 
Uses 
 Sulfur is used in the vulcanisation of black rubber, as a fungicide and in black 
gunpowder. Most sulfur is however used in the production of sulfuric acid, 
which is perhaps the most important chemical manufactured by western 
civilisations. The most important use of sulfuric acid is in the manufacture of 
phosphoric acid to make phosphates for fertilisers. 
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 Mercaptans are a family of organosulfur compounds. Some are added to 
natural gas supplies because of their distinctive smell, so that gas leaks can be 
detected easily. They are also used in Silver polish  and in the production of 
pesticides and to eradicate weeds. 
 Sulfites are used to bleach paper and as preservatives in many foodstuffs. 
Many surfactants and detergents are sulfate derivatives. Calcium sulfate 
(gypsum) is mined on the scale of 100 million tonnes each year for use in 
cement and plaster. 
Biological role 
Sulfur is essential to all living beings. It is taken up as Sulfate from the soil or sea 
water by plants and algae. It is used to make two of the essential amino acids needed 
to make proteins. It is also needed in some co-enzymes. The average human body 
contains 140 grams and takes in about 1 gram a day, mainly in proteins.Sulfur and 
Sulfate are non-toxic. However, Carbon disulfide, Hydrogen sulfide and Sulfur 
dioxide are all toxic. Hydrogen sulfide is particularly dangerous and can cause death 
by respiratory paralysis. 
Natural abundance 
Sulfur occurs naturally as the element, often in volcanic areas. This has traditionally 
been a major source for human use. It is also widely found in many minerals 
including Iron pyrites, Galena, Gypsum and Epsom salts. 
Elemental Sulfur was once commercially recovered from wells by the Frasch process. 
This involved forcing super-heated steam into the underground deposits to melt the 
Sulfur, so it could be pumped to the surface as a liquid. 
Modern Sulfur production is almost entirely from the various purification processes 
used to remove Sulfur from natural gas, oil and tar sands. All living things contain 
Sulfur and when fossilised (as in fossil fuels) the Sulfur remains are present. If 
unpurified fossil fuels are burnt, Sulfur dioxide can enter the atmosphere, leading to 
acid rain 
(20)
. 
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                                                        Siddha Aspect  
3. Urginea indica - Narivengayam 
Synonyms 
Kaateerulli, Kaatuvengayam. 
Vernacular Name 
English : Bulb of Indian Squill 
Telugu            : Nakka-vulli-gadda 
Malayam         : Kaatulli 
Kannada  : Adavi-neerulli 
Hindi  : Jangli- pilyx 
Part used 
 Bulb  
Characters 
Suvai       –  Kaippu 
Thanmai  – Veppam 
Pirivu     _  Karppu 
Actions 
 Expectorant 
 Stimulant  
 Emmenagogue 
 Diuretic 
General characters 
     “஥ஞ்நசோடு சீதக஧ம் ஥ோடோதி லபப்புநறும் 
     ஧ஞ்சோக மூ஬ ஧கந்தபம்ந஧ோம் – ஧ஞ்சலணநசர் 
     யடீ்டுள்஭ிம௅க்கும் யிந஦ோத நடநனிந஬! 
     கோட்டுள்஭ி னிங்கிமங்லகக் கண்டு” 
                                 - அகத்தினர் குணயோகடம் 
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Uses  
 Snake poison, Cough, Asthma, Piles and Fistula(21). 
                               
       Fig.No.3. Urginea indica 
                                         Botnanical Aspect – Urginea indica 
Taxonomical classification: 
Plant ID               :  0132 
Family                 :  Liliaceae 
English Name      : Indian Squill, True Squill, Sea Onion. 
Common Name   : Junglipyaz 
Classification 
(22)
: 
Kingdom              :  Plantae 
Sub kingdom        :  Tracheobionta 
Division                :  Mangnoliophyta 
Class                     :  Magnoliopsida 
Subclass                :  Liliidae 
Order                     :  Liliales 
Family                   :  Liliaceae 
Genus                    :  Urginea 
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Species                  :  Indica 
Part used: 
 Plant and Bulb 
Description of the Plant: 
 A bulbous herb; with truncate bulbs, 5-10 cm long, ovoid.  
 Leaves radical, appearing after the flowers, 15-45 cm long, linear, acute.  
 Scape erect,brittle 30-45 cm long and 4 to 6 mm in diameter at the base.  
 Flowers small, dingy brown, very distant, on slender, laxly flowered racemes, 
15-30 cm long. 
 Fruits  are capsules 1.3-2 cm long, ellipsoid, tapering to both ends, the cells 6 
to 9 seeded. 
 Seeds are flattened and black.  
Medicinal properties 
Bulb  
 Anthelmintic 
 Alexiteric 
 Expectorant 
 Cardiac 
 Deobstruent 
 Emmenagogue 
Plant: 
 Cyanogenetic 
 Expectorant 
Uses 
Bulb is diuretic and cardiac stimulant; used chiefly as a powerful expectorant in the 
treatment of cough, especially in chronic bronchitis and asthma; in large doses it is 
emetic and cathartic and may cause cardiac depression. Its cardio–tonic activity 
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resembles that of digitalis. The extract of bulb also shows hypoglycaemic and 
anticancer activity. 
Juice of the herb is taken with honey. It controls irregular Mensturation. The bulb is 
used for dropsy cure. Becouse of diuretic properties, it helps to increase the urine 
volume. Bulb also cures headaches and diseases of the nose. This is also used to treat 
various other diseases such as Rheumatism,chronic nephritis, ringworm, leprosy and 
scabies.   
ChemicalConstituents 
Bulb 
 Cardiac glycosides, Hentriacontanol, Octacosanoic acid. It also contains 
various Flavonoids including quercetin derivatives and kaempferol 
polyglycosides, Sinistrin, Mucilage and Calcium oxalate. 
 Fresh squill yields at least two Glycosides, Scillaren-A and Scillaren-B(23). 
Root, bulb and leaf 
 Sitosterol, Stigmasterol and Campasterol. 
Tuber  
 Scillarenin 
Habitat 
It is found growing in sandy places, especially, the sea coast in most of the 
Mediterranean districts, being abundant in southern Spain, found in Portugal, 
Morocco, Algeria, Corsica, Southern France, Italy, Malta, Dalmatia, Greece, Syria, 
Canary island and the cape of good hope, India, Africa. It is often grown under fig 
trees in the Italian Riviera,& grown in many botanical gardens and it is stated 
recorded as cultivated plant in England in 1648 & in oxford botanical gardens. 
Ditribution: 
Chittagong, Cox‟s Bazar(23). 
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                                                    3.2. Disease Review 
3.2.1. Siddha Aspect of  the Disease 
Siddha system of medicine deals cancer and its treatment widely. In ancient  Siddha 
literature cancer is explained as in the name of Putru which gives the direct  meaning 
and as Arpudham and Vanmeegam. For the pupose of diagnose and treatment  
following reference books evaluates great ideas about Cancer. 
1. YugiVaidhiyaChinthamani 
2. AnubogaVaidhiyaNavaneetham 
3. Pulipani 500(24) 
4. Agathiya Vaidhiya Vallathi 
5. Agathiyavaithiyavallathi 600(25) 
6. Anubogavaidhiyabhramaragasiyam 
7. Agathiyavaithyagandam 
The great Siddhar Agatthiya in his Vaidhiya Vallathi 600 had explained cancer and its 
different categories. 
    “ந஧ோக்குநந திநிர்யோத நண்லடசூல஬ புற்றுடந஦ 
    நகட்குநந அலபனோப்பு ஧வுத்திபத்லதக் நகள் 
    தண்டு சூல஬மனோடு ஬ிங்கப் புற்ந஫” 
- அகத்தினர் லயத்தின யல்஬ோதி  
   “஥ோநப்஧ோ கம௅ங்கிபந்தி நனோ஦ிப்புற்று 
   ஆநப்஧ோ கம௅யமிக்குங் கிபந்தி ஬ிங்கப்புற்று” 
- ம௄கி லயத்தின சிந்தோநணி 
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    “இம௅புடரி நு஦ி ஥ோசி சி஬ந்தி புற்று 
    தடர்சி஬ந்தி ஧டர்சி஬ந்தி அல்குல் புற்று 
    ஧ின்கபப்஧ோன் முங்கபப்஧ோன் அண்டப் புற்று 
    துணியோத உந்திப்புண் துலடனில் புற்று 
    கீழ்஥ோக்கு நநல்஥ோக்குப் புற்றுப் ந஧ோநந”  
- பு஬ிப்஧ோணி 500 
The unique saint Pulipani also dealt with different type of cancer in his Pulipani 500. 
   “ஓநந஦ி குமிப்புற்று நனோ஦ிப்புற்று 
   ஒ஭ியோ஦ இடிப்புற்று கன்஦ப்புற்று” 
                                     - ம௄கி லயத்தின சிந்தோநணி   
In this medical system of life, the cancerous growth and tumors are headed as Arputha 
viranangal and  Arputha kattigal. 
According to Yugimamunivar Vaithiya Chinthamani 800 part I, some kinds of cancer 
clarified  under different systemic diseases. 
Yugi classifications  of diseases are compared with Modern system of medicine by 
names of symptoms for quick and easy approach
(26)
. 
For example,  
 Ukkarasoolai is understand as prostatic cancer 
 Vilperuvayiru can be compared with Testicular cancer 
 Mamisamagotharam and Kalperuvayiru as cancerous growth within the  
abdomen. 
 Cancer  is considered as Vippuruthi. 
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Types of Vippuruthi 
Vippurithi is classified into 7 types, 
1. Karppa Vippuruthi 
2. Kuvalai Vippuruthi 
3. Vatha Vippuruthi 
4. Pitha Vippuruthi 
5. Sutthuma Vippuruthi 
6. Santhu Vippuruthi 
7. Odu Vippuruthi 
Appearance  
Cancerous growth appear like, 
 Solid tumor -  Kazhalaikatti 
 Spreading ulcer 
 Initially like warts then growth  develops as turtle shell with oozing . 
 Hyper pigmentation of skin, affects hair follicles and destroys entire body. 
Classification: 
Cancer classified into 3 types according its spreading nature ( Metastasis) 
 Skin and its structures 
 Muscles  
 Blood vessels and bones 
Causes  
 Vitamin and mineral deficiency 
 Increased  sexual activity 
 Prolonged starvation 
 Excessive use of tobacco  
 Excessive  intake of hot  and spice food 
 Taking excessive amount of salt and pungent food stuffs 
 Taking large quantity of fish and meat 
 Sleeping  in the  day time. 
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Symptoms  
Symptoms  vary depending on the particular type of cancer. 
                                             Yoni Putru 
Yoni means birth passage. This is cervix of uterus. So the cancer of cervix is known as 
Yoniputru. It is also called Karuppai kazhunthu putru. 
Symptoms 
 Growth in cervix appearing like small grains. 
  Discharge like honey 
 Hardening of surface 
 Profuse bleeding  
 Constipation 
 In some patients discharges with intolerable foul smell. 
 Oliguria and anuria 
 Administration of diuretics causes haematuria. 
Discharges classified into 3 types 
1. Viscous yellowish discharge 
2. Yellow discharge with mucous 
3. Bloody discharge due to non healing  cervical ulcer and cancer of cervix. 
The SiddharYugi in his Vaidhiya Sinthamani mentioned  the symptoms  of Yoniputru 
in different types as follows, 
Kuruthiyoni 
(27a) 
”தி஫நோ஦ வு஧த்திபய நதிகங் கோணும் 
             மத஭ினோத பத்தமுடன் சீழ்஥ீர்ப் ஧ோய்ச்சல் 
 க஫நோ஦ நுலபம௃டந஦ ந஥ோம௃ண்டோகும் 
            கடி஦நோஞ் சலதம௃டந஦ குத்தல் கோணும் 
஥ி஫நோ஦ நஞ்சளுடன் கசநபோ கந்தோன் 
             ஥ில஬னோது யல்கு஬ிந஬ புழுநயோ மநத்த 
ந஬நோ஦ மசோல்஬துவு முளுத்தோற் ந஧ோ஬ 
              நஞ்லைனோ ஦ி஫ம்ந஧ோல் நசக்கும் ஧ோநப.” 
                                     
- ம௄கி மு஦ி 
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Profuse  bleeding  with  mucous, micro ulcers like pits on the wall of cervix, 
discoloration of os. 
Kuruthicheezhyoni
(28)
: 
“஧ோநபதோநன் நயதல஦ நிகவுண்டோகும் 
         ஧ோங்கோ஦ சீழுடன் பத்தங் கோணும் 
சீநபதோன் ஒழுக்குடன் ஥ோற்஫நோகும் 
          சித஫ிநன ஧஬ந஧த யண்ணங் கோட்டும் 
ந஥நபதோ ஥ிதம்஧த்தின் ஸ்த஦ந் தன்஦ில் 
           ம஥டிதோ஦ நபோகத்லத நநயச் மசய்ம௃ம் 
நயநபதோன் மசோன்஦஧டி சிகிச்சோ சோபம் 
          யிரித்திட்டர் ம௄கிமு஦ி யி஭க்கந் தோந஦.” 
 
                                  - ம௄கி மு஦ி 
 
Bleeding  with mucous  sometimes in multicolor, foul smelling discharge with bad 
odour, spread to whole uterus. 
Mamisamagotharam
(27b)
: 
“ந஧ோக்கோ஦ நோநிசந்தோன் ய஭ர்ந்து நீ஫ி 
        ம஧ோம௅நிநன அடியனிற்஫ில் கல்ல஬ப் ந஧ோ஬த் 
தோக்கோ஦ சடந்தோனு மு஬ர்ந்து யற்஫ி 
        தயிக்குநந னடிக்கடிதோன் கண்ணரீ் நதடி 
யோக்கோ஦ நதுபமநோமி கு஭஫ிப் ந஧சி 
        யோய்வுதோ ஦டிக்கடிக்கு நநந஬ ந஥ோக்கும் 
஥ீங்கோ஦ ந஬ச஬நிதில் நோநிசங் கோணும் 
       ந஥போ஦ நோநிச நநகோதபத்தி ந஦நப.”  
 
                                     - ம௄கி மு஦ி 
There are various treatments available especially for Yoniputru in Siddha medicine. 
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  3.2.2. Modern Aspect 
Cancer 
Cancer is a class of diseases characterized by out-of-control cell growth.There are 
over 200 different types of cancer  and each is classified by the type of cell that is 
initially affected. 
More dangerous or malignant tumors form by the following methods:  
 a cancerous cell manages to move throughout the body using the blood or 
lymphatic systems, destroying healthy tissue in a process called invasion 
 that cell manages to divide and grow, making new blood vessels to feed itself 
in a process called angiogenesis. 
When a tumor successfully spreads to other parts of the body and grows, invading and 
destroying other healthy tissues, it is said to have metastasized. This process itself is 
called metastasis and the result in serious condition that is very difficult to treat. 
According to the American Cancer Society, Cancer is the second most common 
cause of death in the US and accounts for nearly 1 in every 4 deaths. The World 
Health Organisation estimates that, worldwide, there were 14 million new cancer 
cases and 8.2 million cancer-related deaths in 2012. 
Individual types of cancer 
There are said to be over 200 different types of cancer. Some of the cancer types are 
as follows, 
 Anal cancer 
 Bladder cancer 
 Bone cancer 
 Breast cancer 
 Cervical cancer 
 Colon cancer 
 Colorectal cancer 
 Endometrial cancer 
 Kidney cancer 
 Leukemia 
 Liver cancer 
 Lymphoma 
 Ovarian cancer 
 Pancreatic cancer 
 
 
 Prostate cancer 
 Stomach cancer 
 Testicular cancer 
 Thyroid cancer 
 Vaginal cancer 
 Vulvar cancer 
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Causes of cancer 
Genes - the DNA type 
Cells can experience uncontrolled growth if there are mutations to DNA, and 
therefore, alterations to the genes involved in cell division. 
Carcinogens  
Carcinogens are a class of substances that are directly responsible for damaging DNA, 
promoting or aiding cancer. Some examples of carcinogens  are, 
 Tobacco 
 Asbestos, Arsenic 
 Radiation such as gamma and x-rays, 
 The Sun rays 
 Compounds in car exhaust fumes  
When our bodies are exposed to carcinogens, free radicals are formed that try to steal 
electrons from other molecules in the body. Theses free radicals damage cells and 
affect their ability to function normally. 
Other Medical Factors  
As we age, there is an increase in the number of possible cancer-causing mutations in 
our DNA. This makes age an important risk factor for cancer. Several viruses have 
also been linked to cancer such as, 
 Human Papillomavirus (a cause of cervical cancer) 
 Hepatitis B and C (causes of liver cancer) 
 Epstein-Barr virus (a cause of some childhood cancers) 
 Human immunodeficiency virus (HIV)  
 Anything else that suppresses or weakens the immune system - inhibits the 
body's ability to fight infections. 
 Increases the chance of developing cancer. 
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Cancer classification: 
There are five broad groups that are used to classify cancer. 
 Carcinomas are characterized by cells that cover internal and external parts of 
the body such as lung, breast  and colon cancer. 
 Sarcomas are characterized by cells that are located in bone, cartilage, fat, 
connective tissue, muscle and other supportive tissues. 
 Lymphomas are cancers that occurs or originates in the lymph nodes and 
immune system  of tissues. 
 Leukemias are cancers that begin in the bone marrow and often  affects the 
blood cells. 
 Adenomas are cancers that arise in the thyroid, the pituitary gland, the adrenal 
gland and other glandular tissues
(29)
. 
                                                    Cervical cancer 
 Cervical cancer is the most common cancer in women aged 35 and below.  
Cervical cancer is a type of cancer that occurs in the cells of the cervix. The cervix is 
the organ connecting the uterus and vagina. 
 It is usually a slow- growing cancer that may not have symptoms but can be found 
with regular pap tests. This is a procedure in which cells are scraped from the cervix 
and looked at under a microscope
(30)
. Cervical cancer is not thought to be hereditary. 
In 99.7% of cases, cervical cancers are caused by persistent infections with a virus 
called high-risk human papillomavirus (HPV).  
HPV is a very common virus transmitted through skin to skin contact in the 
genital area. Around four out of five sexually active adults (80%) will be infected 
with some type of HPV in their lives. However, for the majority of women this will 
not result in cervical cancer. While HPV infection is common, cervical cancer is 
rare
(31)
. There are two types of cervical cancer .  squamous cell carcinomas (80% to 
90%) and adeno carcinomas (5% to 20%).  
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If the cancer has signs of both types, it is called mixed carcinoma. Early  
detection  and  treatment  of  cervical cancer is important to improve survival. 
                                
                                     Fig.No.4.  Shows Cervical cancer 
History of Cervical Cancer
(32)
 
Table  No. 1.  
Year/ 
Period 
Key developments 
19th 
century 
Cervical cancer is identified as a sexually transmitted disease. At the end 
of the century, surgery is introduced for treating the disease. 
Early 20th 
century 
Epidemiologists discover that cervical cancer is common in female sex 
workers and also common in women whose husbands have a high 
number of sexual partners or were regular customers of prostitutes.  
1920s 
Papanikolaou develops his eponymous technique. The colposcope is 
developed. 
1940s Pap smear screening begins.  
1980s 
First concrete evidence that specific Human Papillomavirus (HPV) types 
are linked to cervical cancer. Tobacco use is linked to cervical cancer. 
2000s 
First Human papilloma virus (HPV) vaccine is released. Several nations 
introduce the vaccination, such as United 
States, Canada, Australia and Japan. 
Recent 
years 
Today, cervical cancer is both the fourth-most common cause of cancer 
and the fourth-most common cause of death from cancer in women. In 
2012, approximately 528,000 cases of cervical cancer occurred, with 
266,000 deaths.This is about 8% of the total cases and total deaths from 
cancer.About 70% of cervical cancers occur in developing countries. 
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Prevalence – Cervical Cancer 
Cervical cancer has emerged as a second most common cause of cancer deaths 
among Indian women aged between 15 and 44 years, according to a report by Spain-
based international public health institution Institute Catalàd‟Oncologia (ICO) 
Information Centre. 
On an average, India reports about 122,000 new cases of cervical cancer 
annually, with around 67,500 women succumbing to the disease, accounting for 
11.1% of total deaths related to cancer.Cervical cancer comes next  to breast cancer in 
terms of mortality rate in Indian women. 
The two preventive strategies for cervical cancer include screening and 
vaccination. The report says just 3.1% women in India get screened, leaving a large 
population vulnerable to death from the disease. 
 
According to internationally accepted protocol, all women of 25-64 years need 
to undergo screening every three years.If cervical abnormalities are detected at an 
early stage the abnormal tissue can be excised using day care by minimally invasive 
surgical procedures. 
“Western countries, especially Europe, have taken cervical cancer very 
seriously even 40 years back and every women there get compulsorily screened; 
unfortunately in India it‟s not seen as a priority by the Government – although one-
fourth of cervical cancer deaths occur in India,” said Sharda Jain, gynaecologist and 
director at Global Institute of Gynecology, Delhi
(33)
. 
Predisposing Factors
(34)
 
 Average age 35-45 years 
 Coitus before the age of 18 years 
 Multiple sexual partners 
 Delivery of the first baby before the age of 20 years 
 Multiparty with poor birth spacing between pregnancies. 
 Poor personal hygiene 
 Poor socioeconomic status 
 Previously, exposure to smegma from uncircumcised partners was considered 
an important  for lower incidence of cancer cervix amongst the Jews and 
Muslims. 
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 Smoking and alcohol 
 Contraceptive pill- long term use of some common contraceptive pills slightly 
raises a women‟s risk. 
 Long- term mental stress  
 Women with STD, HIV infection, herpes simplex virus 2 infection, HPV 
infection (16, 18, 31, 33) or condylomata have a high predisposition to cancer. 
 Immuno suppressed individuals (following transplant surgery) 
 Women with pre invasive lesions 
 Women who do not come for regular health check-up and pap test. 
Human papillomavirus (HPV) 
 
                                            
                                 Fig .No. 5. Showing  Human papilloma virus 
                                                        
Human papilloma virus (HPV) is an extremely common virus. HPV is the 
most widespread of all sexually transmitted viruses; four out of five (80%) of the 
world's population will contract some type of the virus once in their life.  
If you catch HPV, in the majority of cases the body's immune system will 
clear or get rid of the virus without the need for further treatment.  
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There are over 100 identified types of HPV and each different type has been 
assigned a specific number. The majority of HPV types infect the skin on external 
areas of the body, including the hands and feet.For example, HPV types 1 and 2 cause 
verrucas on the feet. Different types affect different parts of the body, causing lesions.   
 Around 40 of the HPV types affect the genital areas of men and women, 
including the skin of the penis, vulva (area outside the vagina), anus and the 
linings of the vagina, cervix and rectum . 
  Around 20 of these types are thought to be associated with the development 
of cancer. The World Health Organization (WHO) International Association 
for Research on Cancer (IARC) defines 13 of these 20 types as oncogenic 
(cancer causing). 
 These high-risk types of HPV are 
 
 HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68. A person infected 
with a high-risk genital HPV will show no symptoms. 
 In addition, there are nine HPV types that may also be associated with the 
development of cervical cancer, these are HPV 26, 53, 64, 65, 66, 67, 69, 70, 
73 and 82. 
 The remaining genital HPV types have been designated low risk as they do 
not cause cervical cancer but they can cause other problems, such as genital 
warts
(35)
. 
 Pathology 
 
Pap smear in invasive cancer shows tadpole cells, haemorrhage and necrosis in 
the background. It is customary to identify two types of cancers of the cervix. The 
first and more common variety is the epidermoid carcinoma. It arises from the 
stratified squamous epithelium of the cervix  and accounts for almost 80% of all 
cancers in the cervix.   
    
The second variety endocervical carcinoma arises from the mucous membrane 
of the endocervical canal, accounts for 20% of all cervical cancers.             
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                                                      Fig.No. 6. HPV infection  
Histologically, 95 percent of cervical cancers are squamous carcinomas and only 5 
percent are adenocarcinoma. This is because the columnar epithelium of the 
endocervix often undergoes squamous metaplasia. Endocervical cancers of the cervix 
have recently increased in incidence because of prolonged use of oral combined 
contraceptive pills and  progesterone‟s which have profound effect on glandular 
epithelium. 
 The malignant cells are endometroid, adenocarcinoma, clear cells and 
adenosquamous. 
Squamous cell cancers of the ectocervix appear as proliferative growths, 
ulcers or as flat indurated areas. The common proliferative or cauliflower-like growth 
is vascular, friable and bleeds on touch.  
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It undergoes ulceration and necrosis, which is associated with an offensive foul 
smelling vaginal discharge. The leucorrhoeal discharge is often blood stained. 
Histologically, the tumor is graded as well-differentiated or ill-differentiated. The 
endocervical growth remains confined to the cervical canal for a long time causing a 
barrel-shaped enlargement of the cervix, and only at a late stage it protrudes beyond 
the external cervical os and becomes visible.  
 
The mode of spread of the cancer is by continuity or by continuity, by lymphatic 
spread or through vascular embolism to distant sites like lungs, liver, bones, kidneys 
and brain. Ovarian metastasis occurs in only 1 percent. 
Cervical cancer symptoms
(36) 
In the early stages of cervical cancer, a person may experience no symptoms at all. As 
a result, women should have regular cervical smear tests. 
The most common symptoms of cervical cancer are: 
 bleeding between periods 
 bleeding after sexual intercourse 
 bleeding in post-menopausal women 
 discomfort during sexual intercourse 
 smelly vaginal discharge 
 vaginal discharge tinged with blood 
 pelvic pain 
Stages of Cervical cancer 
  
Stage I 
 Carcinoma strictly conflicted to the cervix IA Micro 
invasive carcinoma, not exceeding 5.0mm. 
 IA1 Measured stromal invasion of less than 3.0mm in depth.  
 IA2 Measured stromal invasion between 3 and 5mm in depth.  
 IB Clinically visible lesion confined to the uterus 
 IB1 Clinically visible lesion 4.0cm. 
 IB2 Clinically visible lesion more than 4.0cm in dimension. 
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Stage II  
 Cancer spread beyond the cervix, but not to pelvic wall or lower third of the 
vagina. 
 IIA Tumor without parametrical invasion. 
 IIB Tumor with parametrical invasion. 
Stage III  
 Tumor extends to the lateral pelvic wall, involves the lower third of vagina, 
and/or causes hydronephrosis or non functioning kidney. 
Stage IV  
 Tumor spread to the pelvic organs or distal metastasis.  
 IVA Tumor involves bladder and rectum. 
 IVB Widespread tumor with distant metastasis. 
 
Differential Diagnosis: 
 Tubercular ulcer 
 Syphilitic ulcer 
 Fibroid polyp 
 Sarcoma of the cervix 
Diagnosis 
(37)
 
The earlier cervical cancer is diagnosed, the more successful treatment  can be done. 
Regular cervical screening can save thousands of lives every year. 
 Cervical smear test 
 HPV DNA Test 
Additional tests including 
 Biopsy  
 Colposcopy 
 Cone biopsy 
 LLETZ  
 Blood tests  
 Examination under anesthesia (EUA) 
 CT scan 
 MRI 
 Pelvic ultrasound  
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Treatments for Cervical cancer
(38) 
Surgery for Cervical cancer 
Several types of „surgery‟ can be used to help treat cervical cancer, although some of 
these destroy cervical tissue (with cold or with laser) rather than removing it. 
 Cryo surgery 
 Laser surgery 
 Conization 
 
Simple (total) hysterectomy:  
This surgery removes the uterus (both the body of the uterus and the cervix) but not 
the structures next to the uterus (parametria and uterosacral ligaments). The vagina 
and pelvic lymph nodes are not removed. The ovaries and fallopian tubes are usually 
left in place unless there is another reason to remove them. 
There are different ways to do a hysterectomy: 
 Abdominal hysterectomy 
 Vaginal hysterectomy 
 Laparoscopic hysterectomy 
 Laparoscopic-assisted vaginal hysterectomy 
 Robotic-assisted surgery 
Possible side effects: 
 infertility (inability to have children). 
 excessive bleeding, 
 wound infection or damage to the urinary or intestinal systems. 
Radiation therapy for Cervical Cancer
(39) 
Radiation therapy uses high energy x-rays or radioactive particles to kill cancer cells. 
Radiation therapy may be used for cervical cancer. 
The two types of radiation therapy most often used to treat cervical cancer include: 
1. External beam radiation 
2. Brachytherapy 
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External beam radiation 
One way to give radiation is to aim x-rays at the cancer from outside the body. This is 
called External beam radiation therapy (EBRT). Treatment is much like getting a 
regular x-ray, but the radiation dose is stronger. 
Each radiation treatment lasts only a few minutes, but getting you into place for 
treatment usually takes longer. The procedure itself is painless. 
When radiation is used as the main treatment for cervical cancer, EBRT is usually 
combined with chemotherapy (called concurrent chemoradiation). Often, a low dose 
of the chemo drug called cisplatin, but other chemo drugs can be used as well. The 
radiation treatments are given 5 days a week for a total 6 to 7 weeks. The 
chemotherapy is given at scheduled times during the radiation. The schedule is 
determined by which drug is used.EBRT can also be used by itself to treat areas of 
cancer spread or as the main treatment of cervical cancer in patients who can‟t tolerate 
chemoradiation. 
Possible side effects of EBRT 
Side effects of external beam radiation therapy for cervical cancer can include: 
 Fatigue (tiredness) 
 Upset stomach 
 Diarrhea or loose stools (if radiation is given to the pelvis or abdomen) 
 Nausea and vomiting 
 Skin changes 
 Radiation cystitis 
 Vaginal pain 
 Menstrual changes 
 Low blood counts 
Brachytherapy 
Brachytherapy or internal radiation therapy, puts a source of radiation in or near the 
cancer. This type of radiation only travels a short distance. The type of brachytherapy 
used most often to treat cervical cancer is known as intracavitary brachytherapy. 
The radiation source is placed in a device in the vagina (and sometimes in the cervix). 
This is often used in addition to EBRT as a part of the main treatment for cervical 
cancer. 
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There are two types of brachytherapy: 
 Low-dose rate (LDR) brachytherapy  
 High-dose rate (HDR) brachytherapy  
Possible short-term side effects of brachytherapy 
Since the radiation only travels a short distance with brachytherapy, the main effects 
of the radiation are on the cervix and the walls of the vagina. The most common side 
effect is irritation of the vagina. It may become red and sore and there may be a 
discharge. The vulva may become irritated as well. 
Brachytherapy can also cause many of the same side effects as EBRT, such as fatigue, 
diarrhea, nausea, irritation of the bladder and low blood counts.  
Often brachytherapy is given right after external beam radiation (before the side 
effects can go away), so it can be hard to know which type of treatment is causing the 
side effect.   
Long term side effects of radiation therapy 
 Vaginal stenosis 
 Vaginal dryness 
 Weakened bones 
 Swelling of the legs 
Chemotherapy
(40)
 
Chemotherapy (chemo) uses anti-cancer drugs that are injected into a vein or given by 
mouth. These drugs enter the bloodstream and can reach all areas of the body, making 
this treatment useful for killing cancer cells in most parts of the body. Chemo is often 
given in cycles, with each period of treatment followed by a recovery period. There 
are a few situations in which chemo may be recommended for cervical cancer. 
 As a part of the main treatment for cervical cancer 
For some stages of cervical cancer, the preferred treatment is radiation and chemo 
given together (called concurrent chemoradiation). The chemo helps the radiation 
work better.  
Options for concurrent chemoradiation include: 
 Cisplatin given weekly during radiation. This drug is given into a vein (IV) 
about 4 hours before the radiation appointment. 
                                                                                                                         REVIEW OF LITERATURE 
 
ANTI – CANCER ACTIVITY OF RASAPARPAM PAGE 43 
 
 Cisplatin plus 5-fluorouracil (5-FU) given every 4 weeks during radiation. 
Sometimes chemo is also given (without radiation) before and/or after 
chemoradiation. 
Side effects of chemotherapy for cervical cancer: 
Chemo drugs kill cancer cells but also damage some normal cells, which can lead to 
certain side effects. Side effects depend on the type and dose of the drugs and the 
length of time you are treated.  
 Nausea and vomiting 
 Loss of appetite 
 Loss of hair 
 Mouth sores 
 Fatigue (tiredness) 
Because chemotherapy can damage the blood-producing cells of the bone marrow. 
This can result in: 
 An increased chance of infection (from a shortage of white blood cells) 
 Bleeding or bruising after minor cuts or injuries (because of a shortage of 
blood platelets) 
 Shortness of breath (due to low red blood cell counts) 
When chemo is given with radiation, the side effects are often more severe. Nausea, 
fatigue and problems with low blood counts are often worse. Diarrhea can also be 
worse if chemo is given at the same time with radiation and the following side effects  
can occur, 
 Menstrual changes 
 Neuropathy 
 Increased risk of leukemia 
Other side effects are also possible. Some of these are more common with certain 
chemo drugs. Many side effects are short-term and go away after treatment is 
completed, but some can last for a longer time or even be permanent.  
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Targeted therapy /  Immunotherapy  for Cervical Cancer
(41) 
 
 Targeted therapy is a type of treatment that uses drugs or other substances to 
identify and attack specific cancer cells without harming normal cells. 
 Monoclonal antibody therapy is a type of targeted therapy that 
uses antibodies made in the laboratory from a single type of immune 
system cell.  
  Bevacizumab is a monoclonal antibody that binds to a protein called vascular 
endothelial growth factor (VEGF) and may prevent the growth of new blood 
vessels that tumors need to grow. Bevacizumab is used to treat cervical cancer 
that has metastasized (spread to other parts of the body) and recurrent cervical 
cancer. 
The Vaccines
(42) 
There are currently two vaccines which protect against HPV infection, which are 
called Gardasil and Cervarix. 
 Gardasil 
produced by Merck, is designed to protect against four types of HPV 
 16 and 18 (high risk for cervical cancer) 
 6 and 11 (these types do not cause cervical cancer, but they do 
cause 90% of genital warts) 
 Cervarix 
produced by GlaxoSmithKline, is designed to protect against HPV types 16 and 18 
only 
Both vaccines are licensed in the UK. The NHS currently uses Gardasil to vaccinate 
girls. 
 There is also a third vaccine called Gardasil 9.  
 This protects against high risk HPV types 16, 18, 31, 33, 45, 52 and 58, as 
well as HPV 6 and 11. Gardasil 9 has been approved for licensing by the 
Committee for Medicinal Products for Human use of the European Medicines 
Agency. This vaccine is likely to be given its licence by the European 
Commission later this year. 
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 The vaccination is free for all girls from the age of 11 in Scotland and 12 in 
the rest of the UK up to their 18
th
 birthday, but only girls aged 11 to 13 in 
Scotland and 12 to 13 in the rest of the UK will be routinely offered the 
vaccine. 
  The vaccination is given to girls at this age because their immune systems are 
at their strongest before puberty begins and the vaccination works best when 
the immune system is strong. 
 HPV vaccination has been shown to prevent infection and abnormal cervical 
cell changes for at least 10 years, but modelling suggests it will last longer. 
Ongoing studies will show how much longer young women will be protected 
for and whether booster shots will be required. 
Both Gardasil and Cervarix protect against the two highest risk HPV types. However, 
unfortunately, women can be infected with more than one type of HPV. Having the 
vaccine will provide protection against 70% of all cervical cancers and it will also 
prevent most of the more serious precancerous cervical changes (classed as moderate 
or severe cervical abnormalities) . 
Prevention of cervical cancer
(43) 
There are a number of measures that can be taken to reduce the chances of developing 
cervical cancer. 
 Human papillomavirus (HPV) vaccine 
 Safe sex and cervical cancer 
 Cervical screening 
 Having fewer sexual partners 
 Delaying first sexual intercourse  
 Stopping smoking  
                                           3.3. Pharamacolgical Review 
3.3.1. Siddha Aspect 
Siddha system of medicine  gave us so many drugs for different type of cancers.  
Some important medicines  are mentioned below,  
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Pills: 
 Chithiramoolaakuligai(44)  
 Maha Kodasoozhi Mathirai 
 Aswaganthathi vadagam 
Chooranam 
 Vallathy Chooranam 
 Megaroga Chooranam  
 Kukkilathy Chooranam 
 Garudakodi Chooranam 
 Sorkkamara Chooranam 
 Thumbai Chooranam 
 Vembadam pattai Chooranam 
 Karanthai Chooranam(45)  
Parpam: 
 Thambira Parpam(46)  
 Gandhaga Poora Parpam(47) 
 Kariya Parpam 
 Sootha Parpam 
 Rasa Parpam 
 Naga Parpam 
 
 Thalaga Parpam 
 Sandarasa Parpam 
Chendhooram: 
 Panchapadana Chendhooram(48) 
 Swaranapushpa Rasa Chendhooram(49) 
 Muthu Chendhooram(50) 
 Kandhaga Chendhooram 
 Gowri Chinthamani Chendhooram 
 Linga Chendhooram 
 Rasa Chendhooram 
 Thambira Chendhooram 
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 Pavala Vanga Chendhooram 
 Kalamega Narayana Chendhooram 
 Kalameganarayana Chendhooram(51) 
 Ashtapairava Chendhooram 
 Sandamarutha Chendhooram 
 Navachara Chendhooram 
 Naga Chendhooram(52) 
 Namatchivaya Chendhooram(53) 
 Narayana Chendhooram(54) 
Nei: 
 Chitramoola Nei(55)  
 Kukkil Nei 
 Thengai Nei 
 Vallarai Nei 
Ennai:
 
 Perungaya Ennai(56) 
 Singi Thylam 
 Mega Santhanathy Thylam 
 Chinthamani Ennai 
 Meganathi Ennai 
 Visha Rajanga Thylam 
 Pachai Thylam 
 Vippuruthi Ennai 
 Sengathari Thylam 
 Mega Rasanga Ennai 
 Puda Thylam 
 Gandhaga Thylam(57)  
 Sengottai Thylam 
Mezhugu: 
 Rasagandhi Mezhugu(58) 
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 Kanaga Linga Mezhugu 
 Guru Sanjeevi Mezhugu 
 Vaalai Rasa Mezhugu 
 Gandhaga Mezhugu(59) 
 Korasanai Mezhugu 
 Veera Mezhugu 
Kattu: 
 Poorakattu(60) 
Pathangam:  
 Lingapathangam(61) 
 Gurupathangam  
 Putru pathangam 
 Veera Rasa pathangam 
Others : 
 Rana Pugai 
 Veelai seelai  
 Kulirntha pachai 
 Chithiravallathi Legium 
Siddha drugs for Yoniputru 
Pills : 
 Chitramoola Kuligai 
Chooranam: 
 Karanthai chooranam 
Parpam: 
 Thambira Parpam 
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 Velli Parpam 
 Gandhaga Parpam 
 Karuvanga Paarpam 
Chendhooram: 
 Muthu Chendhooram 
 Namachivaya Chendhooram 
 Swarnapushpa Rasa Chendhooram 
 Panchapadana Chendhooram 
Thylam: 
 Chitramoola Nei 
 Vallarai Nei 
 Megathu Ennai 
 Gandhaga Thylam 
 Sathrusangara Ennai 
 Perungaya Ennai 
 Meganathi Thylam 
Mezhugu: 
 Vithu Rasa Meazhugu 
 Korosanai Mezhugu 
 Rasaganthi Mezhugu 
 Gandhaga Mezhugu 
 Amirtha Nandhi Mezhugu 
Kattu: 
 Poora Kattu 
Pathangam: 
 Linga pathangam 
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Kirutham: 
 Vallarai kirutham 
Others: 
 Gandha Rasa Villai 
 Megam pokkum Rasagandhi 
 Soolai Kudori   
                                                     3.3.2. Modern aspect 
Anti-cancer drugs  
The drugs which prevent neoplasm are known as anti-cancer drugs. They also called 
Anti-neoplastic drugs. 
Purpose  
Anti –cancer drugs are used to control the growth of cancerous cells. Cancer is 
commonly defined as the uncontrolled growth of cells, with loss of differential and 
commonly, with metatasis, spread of the cancer to other tissues and organs. 
Cancers aremalignant growths. In contrast , benign groths remain encapsulated and 
grow within a well-defined area. 
Drug therapy is used when the tumor has spread or may spread, to all areas of the 
body. 
They may be divided into two classes 
Cycle specific  
Cycle specific drugs act only at specific points of the cell‟s duplication cycle, such as 
anaphase or metaphase. 
Non cyclic specific  
Drugs may act any point in the cell cycle, in order to gain maximum effect, anti-
neoplastic drugs are commonly used in combinations. 
Precautions: 
Because anti neoplastic agents  do not target specific cell types, they have a number of 
common adverse side effects.  
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 Hair loss is common due to the effects on hair follicles 
 Anaemia 
 Immune system impairment 
 Clotting problem are caused by destruction of the blood forming organs, 
leading to reduction in the number of red cells, white cells and platelets. 
 Bone marrow depression 
Interactions:  
Anti- cancer drugs may interact with a number of other medicines. When this 
happens, the effects of one or both of the drugs may change or the risk of side effects 
may be greater. 
Clasification of Anti-cancer drugs
(62) 
1. Alkylating agents 
2. Antimetabolites 
3. Natural products 
4. Miscellaneous 
5. Hormones and Antagonist 
Alkylating agents 
 Cyclophoshamide 
 Ifosfamide  
 Triazene  
 Methyl hydrazines 
 Alkylsulfonates  
 Cisplatin 
 Carboplatin 
 Oxaliplatin 
 Nitrosoureas  
 Melphalan  
Antimetabolites  
 Methotrexate 
 Purine antagonists 
 Pyrimidine antagonists- 5-fluorouracil 
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Natural products 
 
Plant products 
 Vincristine  
 Vinblastin 
 Taxanes- Paclitaxel 
 Etoposide  
Micro-organism products 
 Antibiotics- Doxorubicin, Bleomycin 
 L-Asparaginase 
Miscellaneous  
 Hydroxyurea 
 Imatinib Mesylate 
 Leucovorin 
 Geftinib 
 Pamidronate 
 Gemcitabin 
Hormones & Antagonists 
 Dexamethasone 
 Prednisone 
 Ethinyloestradiol 
 Megestrol acetate 
 Flutamide 
 Letrozole  
 Growth hormone 
 Glucagon  
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Table No.2. Anti cancer drugs
(63) 
Generic ( Brand 
Name) 
Clinical Uses 
Common side effects to 
Drug 
Altretamine(Hexalen) 
Treatment of advanced 
ovarian cancer 
Bone marrow depression, 
nausea, and vomiting. 
Asparaginase (Elsper) 
Commonly used in 
combination with other drugs; 
refractory acte lymphocytic 
leukemia 
Liver, Kidney, pancreas, 
CNS abnormalities. 
Carboplatin (Paraplatin) Palliation of  ovarian cancer 
Bone marrow depression, 
nausea, and vomiting. 
Clorambucil (Leukeran) 
Chronic lymphocytic 
leukemia, non Hodgkin‟s 
lymphomas, breast and 
ovarian cancer.  
Bone marrow depression, 
excess uric acid in blood. 
Bleomycin (Blenoxane) 
Lymphomas, Hodgkin‟s 
disease, testicular cancer. 
Hair loss, stomatitis, 
pulmonary toxicity,hyper 
pigmentation of skin. 
Busulfan (Myleran) 
Chronic granulocytic 
leukemia 
Bone marrow depression, 
pulmonary toxicity. 
Carmustine  
Hodgkin‟s disease, brain 
tumors,, multiplemyeloma, 
malignant melanoma. 
Bone marrow depression 
and vomiting. 
Cisplatin (Platinol) 
Treatment of bladder, 
ovarian,uterine, testicular, 
head and neck cancer. 
Renal toxicity and 
ototoxicity. 
Cyclophosphamide 
(Ctoxan) 
Hodgkin‟s disease, non 
Hodgkins lymphoma, 
neroplastoma. Often  used 
with other drugs for breast, 
ovarian and lung cancer;  
acute lymphoplastic leukemia 
in children. 
Bone marrow depression, 
nausea, vomiting, hair 
loss, inflammation of the 
bladder. 
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Generic ( Brand 
Name) 
Clinical Uses 
Common side effects to 
Drug 
Ethinyl estradiol 
(Estinyl) 
Advanced breast cancer in 
post menopausal women, 
prostate cancer. 
Excessive calcium in 
blood, anorexia, oedema, 
nausea, vomiting; 
feminizing effects  in 
men. 
Mitotane (Lysodren) 
Cancer of the adrenal cortex 
(inoperable) 
Damage to adrenal 
cortex,nausea, anorexia. 
Paclitaxel (Taxol) Adavanced ovarian cancer 
Bone marrow depression, 
hair loss, nausea, 
vomiting, hypotension, 
allergic reactions, muscle 
joint pain. 
Mitomycin 
(Mutamycin) 
Bladder, breast, colon, lung, 
pancreas, rectum cancer. 
 
and n 
B ne marrow depression, 
nausea and vomiting. 
diarrhea 
Tamoxifen (Nolvadex)  
Advanced breast cancer in 
post menopausal women. 
 Nausea,  vomiting , 
ocular toxicity, hot 
flashes. 
 
Pharmacological review of Cancer: 
The pharmacological screening of plants, minerals and animals is an essential mean 
for the invention of new, harmless and effective drugs. Over 50,000 plants have 
therapeutic virtues in the world and around 80% of human use medicines based on 
plants and salts at least once in their life. 
Medicinal plants and mineral share diversified chemical constituents which are 
important for the discovery of new active molecules against many types of Cancer. 
Active compounds from many medicinal plants and minerals with effective cytotoxic 
properties were developed into Anti-Cancer drugs. 
Nowadays it has become mandatory to monitor the quality of life of patients while in 
treatment of Cancer. There should be health awareness in the quality of life of Cancer 
patients treated with chemotherapeutic drugs because they are very much affected 
even for a long time after withdrawal of drugs.  
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Therefore, the challenging task at this moment is to identify the quick and novel 
methods that can identify and develop molecules, which can be of therapeutic value in 
human Cancers.  
This urgently necessitates screening of a large number of compounds. For this 
purpose both, the in-vitro and in-vivo models are employed for systematic screening 
of an Anti-Cancer drug. 
In-Vitro  method 
In in-vitro cytotoxicity studies on cell line various cell staining methods are used in 
order to indirectly estimate the number of viable cells present after treatment. Ideal 
test in assessing cell proliferation and cytotoxicity should have as main feature in-
vitro be simple fast, efficient economical, reproducible, sensitive, safe, effectiveness 
far viable cell population and do not show interference with to evaluate the 
compound. 
Advantages
(64)
 : 
 Reduce the usage of animals 
 Testing the ability  of the compound to kill the cell by taking the advantage of 
various properties of cell. 
 Able to process the large number of compounds quickly with minimum of 
quantity 
 Range of concentration used is comparable to that expected for invivo studies 
Disadvantages: 
 Difficulty in maintaining of culture  
 Show negative result for the compounds which gets activated after metabolism 
and vice versa  
 Impossible to as certain the pharmacokinetics 
How to culture cell line? 
 Tumor cell line derived from several cancer types 
 Adaptable to a suitable growth medium 
 Show reproducible profile for growth and drug sensitivity 
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 The lives were prepared and preserved using regents such as DMSO during 
freezing. 
 Thawing – bringing the freezed ampoule to room temperature by slow 
agitation. 
Cell lines for Cancer: 
There are plenty of cell lines are available for research purpose. Only very few are 
listed. 
Table No.3.   Cancer cell lines 
S.No Cell Name Tissue Species 
1. UM-UC Bladder Human 
2. FM3A Breast Mouse 
3. C170 Colon Human 
4. SHP77 Lung Human 
5. RAG Kidney Mouse 
6. HF 1 Liver Rat 
7. MEWO Skin Human 
8. TT Thyroid Human 
9. OV Ovary Human 
10. C 6 Neural (Gilial tumor) Rat 
 
Assay
(65) 
For energy metabolism and Autophagy: 
 FAD assay 
 ATP assay 
 Lysosome detection` 
For nuclear signaling, DNA damage and cell proliferation 
 P53 assay 
 Topoisomerase II assay 
 P21 assay 
 Cell proliferation assay 
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 Mdm 2 assay 
For Inflammation, Angiogenesis and Metastasis 
 Cytokine and chemokine assay 
 STAT 1,2,3,6  assay 
 COX-2 activity assay 
 LDL uptake assay 
For Apoptosis, Pyroptosis and Necrosis 
 Caspase 1 assay 
 Bax assay 
 Cytolysis assay 
 Calpanin assay 
For cancer signaling pathway and phenotype  
 ERK assay 
 c-AMP assay 
 c-Jun test 
In -Vivo Models 
Many animal species develop cancers spontaneously and are valuable for 
understanding the biology of sporadic cancer development in humans. The major use 
of spontaneous cancer models is to compare the biology with human, in these animals 
are increasingly valuable for cross – comparison of response or resistance to clinical 
agents used for patients
(66)
.  
Animal models 
1. Mouse Cancer models 
  I .GEM – Genetically engineered mouse model 
       II.Inbred mice (systematic sibling mating ) 
III.Transplantation models 
 Allograft models (syngeneric tumor tissue derived from same genetic mouse) 
 Xenograft models (actual human cancer cells or solid tumors are transplanted 
into host mouse) 
      IV. Carcinogen induced and spontaneous models 
                                                                                                                         REVIEW OF LITERATURE 
 
ANTI – CANCER ACTIVITY OF RASAPARPAM PAGE 58 
 
 Digestive system cancer induced by polycyclic aromatic hydrocarbons 
 Chemically cancer induced by Cadmium and Arsenic  
 Radiation-skin cancer by Ultra violet radiation: leukemic changes by ionizing 
radiation. 
2. Rat cancer models 
I .Genetically altered rats 
 Treat embryos with DNA damage causing chemical mutagen. 
Frequently N-ethyl-N – nitrosourea (ENU) is used. 
 Insertion of mutagenesis strategies ( Retro virues) 
 Transgenic strategies (Pro nuclear injection of DNA) – quickly 
developed and more effective models. 
II. Inbred rats 
3. Other laboratory animal models 
 Hamster 
 Rabbits 
 Zebra fish 
4. Other animal  models 
 Dogs 
 Cats 
 Goats 
 Horses 
 Pigs  
There is also work done with various species, such as Baboons, Chimpanzees, 
Macaques, Marmosets and Tamarins.  
Cerviacl cancer cell lines 
 HeLa (HPV 16) 
 SiHa (HPV 18) 
 C 33A (HPV Negative) 
 CaSki 
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Induction  of cervical cancer in  animal models: 
 Cervical neoplasia is induced  in mouse by an extract of varicella zoster virus 
infected cells (HPV or Herpes simplex virus type 2 DNA) 
 Genomic HSV 2 DNA was isolated from infected HE p2 cells and separated 
from host cell DNA by Cesium chloride density gradient centrifugation.  
 The DNA was applied to mouse cervix for period of 80 to 100 weeks. Should  
be examined monthly to detect abnormalities. 
                                               3.4. Pharmaceuctical Review  
Parpam
(67) (68) 
Concept and terminology: 
Parpam is equivalent to calx, which is prepared by a process of calcinations. 
There are rare exceptions to this general concept, where no heating at all is required in 
the process, Muthuparpam is an example where, according to certain  texts, the 
pearls  are simply ground with rose water in to a fine powder . Kungiliya Parpam is an 
example where the drug sal- dammar is not actually calcined, but is heated to melting 
stage with coconut water and then dried and powdered. 
The term Parpam is apparently a tamilized form of the Sanskrit word bhasma. 
The correct tamil translation would be “Neeru”(நீறு) which would mean an 
ash.”Saambal” (சாம்பல்) is another word equivalent to an ash or calx. However, term 
Parpam has held the ground in siddha medicine. 
Parpam are made from the given drugs according to specified methods. The 
drugs taken may either be organic (as in the case of „Kungiliya Parpam‟, 
„Aamaioduparpam‟, or „Peranda Parpam‟) or inorganic ( as in the case of „Kalnaar 
Parpam‟, „Thanga Parpam‟, „Velli Parpam‟) in origin. Accordingly, these may be 
bones or horns , shells or secretions and metals or minerals or ores or salts. 
Chemically, most of the drugs taken are oxidized when they attain the „Parpam’ from 
barring a few. Physically the Parpam is composed of particles in a fine state of 
division, with a major portion in the colloidal dimensions. This ultra fineness is 
obtained  by efficient oxidation and trituration. 
Physiologically, the particle fineness of great importance. Most compounds of 
metals and minerals are not absorbed by the body from the digestive tract, because 
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under ordinary circumstances, these substances could not be reacted upon by the 
secretions of the digestive system, so as to render them absorbable by the organism. 
This difficulty is overcome when the individual particles of this compound are very 
minute.  
For instance, Mica is practically insoluble in water or dilute hydrochloric 
acid.  But, when it is prepared in to a Parpam and is highly comminuted, a 
considerable portion goes in to solution in hydrochloric acid approximately of the 
same strength of gastric juice. 
Similarly, metallic gold produces, toxic symptoms simulating those of 
Arsenic, but in the colloidal state, it has been found to be beneficial to the system. 
This shows the usage of Thanga parpam as an efficient vitalizer in the Siddha system 
from time immemorial. 
 The repeated grinding and heat treatment given to the materials, reduces the materials 
so treated, into different chemical compounds or at least into fine particles, which are 
capable of being acted upon by the system and absorbed and incorporated into the 
tissues. 
Preparation 
Equipments required: 
 Mortar  and pestle 
 Vessels and spoons to handle liquids 
 Long ribbons of tough cloth and fine clay. 
 Pairs of shallow earthen discs of identical dimensions 
  Well dried cow dung cakes in sufficient numbers. 
 Fine cloth pieces for filtering juices and decoctions. 
 Spatula for handling powders. 
Notes on the drugs used: 
 The drugs taken should be clean and those that should be purified should 
necessarily be taken through the process of purification according to the 
convention of Siddha science  
 The materials taken should be properly identified. 
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 Great care should be exercised during the process of handling molten metals 
and pouring them  into specified juices, so as to avoid accidents 
Method of preparation: 
        The drugs are ground according to the particular recipe, with other drugs, juices 
or decoctions and the resultant mass is made into small, thin circular cakes and dried. 
When they are well dried, they are taken for calcinations. 
The materials ready for calcinations, is put into an earthen disc described 
earlier and covered by inverting another disc and sealing the rim with the cloth ribbon 
one side of which is smeared with wet clay. This makes a capsule type crucible. When 
the seal is dry, the capsule is placed in the   kiln for calcinations. 
The Kiln or Pudam as it is called in Tamil, is made by digging a pit of 
appropriate dimensions in the soil and filling it with the recommended number of cow 
dung cakes, which is the fuel. It is better that the interior of the pit is lined with bricks, 
so that the pit could be used repeatedly. 
Seventy five percent of the recommended numbers of dung cakes are arranged 
in the pit and then the capsule (or capsules) is placed in the center. The rest of the 
dung cakes are arranged above this and the top is somewhat dome shaped. When 
some burning charcoal pieces are placed on the dome, the dung cake below them 
catch fire and the fire spreads all around in an uniform manner. 
The kiln will burn for a long time, until all the dung cakes are burnt and 
converted in to ashes. When the kiln cools down, the ashes are very carefully removed 
and the capsule is taken out without damaging the seal.  The exterior of the capsule is 
thoroughly brushed to remove the ashes and the seal is scraped off and removed. 
The content of the capsule are recovered and the remnants that adhere to the 
walls are gathered by gentle scraping and brushing. 
For the complete transformation of the material into the Parpam state , the 
process of grinding , drying and calcinations may have to be repeated several times  or 
at least as many times as directed in the recipe. However, the calcinations is repeated 
until a satisfactory product is obtained. But in those instances where the number of 
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calcinations is definitely indicated, the process should be repeated accordingly, even 
if a satisfactory Parpam is obtained within a few calcinations. 
While preparing the Parpam of Lead, Tin and Zinc the number of dung cakes 
used as fuel , should always be comparatively lesser than the number used for other 
metals, because excessive heating will result in the reversion of the Parpam to the 
metallic state. 
Test for complete calcinations 
      The primary factor being the color of the final product, there are the following 
tests to find whether the given material has been satisfactorily calcined and 
comminuted. 
 As indicated earlier, the color shades attained by different materials when they 
are calcined are of prime importance and this is learnt mostly by experience. 
 A pinch of the Parpam gently placed on the still surface of water in a vessel, 
does not sink immediately 
 When a pinch of the Parpam is taken and pressed between the fingers, the mass 
shows the finger prints and the particles enter the fine folds of the finger, if 
calcinations is satisfactory. 
 The Parpam, if satisfactorily  completed, is irreversible to its metallic state 
when heated with a mixture of cane jaggery, hemp powder ,bdellium , ghee and 
honey      
Storage of  Parpam: 
Parpams are usually stored in glass bottles. For smaller packings, vials of 
glass are used. Encapsulation could also be done when equipment is available. It is 
highly desirable that  preparations be stored and retained in relevantly labeled 
containers. They are said to retain their potency for 100 years if properly stored. 
                                                    3.5. Lateral research 
Urginea indica 
 U. indica, an anti-proliferative assay with ER positive breast cancer cell line 
(MCF-7) and ER negative Breast cancer cell line (BT-549) was performed. 
The aqueous bulb extract of red variety exhibited 82% of anti-proliferative 
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activity against MCF-7 compared to control, whereas white variety inhibited 
62%. 
 The percent of inhibition of DPPH radical was 16.5, 18.0, 14.0, 11.5% with 
aqueous extracts of bulb, leaf, stem and root of white variety 
respectively,whereas 18, 18, 16, 14% respectively, with red variety at 25 
mg/ml. It has Anti-oxidant property
(69)
. 
 The extract of the bulb of Urginea indica Kunth. were collected by using of 
alcoholic extraction. The anti-inflammatory action of the alcoholic Extract 
of the bulb of the plant Urginea indica was evaluated in rats (female) against 
carrageenan induced edema i.e., using plethysmographic method
(70)
 
 The crude aqueous-methanol extract of Urgineaindica bulb (Ui.Cr) was tested 
on mice and isolated gut preparations. Urgineaindica, which was tested 
positive for alkaloids, tannins and coumarins, increased faecal output and 
accelerated charcoal meal transit in mice (6–12 mg/kg, p.o.) This data, 
indicating the presence of a gastrointestinal stimulant effect in Urginea 
indica possibly mediated through a cholinergic mechanism, provide a 
rationale for the use of  Urginea indica in indigestion and constipation
(71)
. 
Sulfur: 
 The growth inhibitory and apoptosis-related effects of a newly developed 
highly purified sulfur (HPS) on immortalized human oral keratinocytes 
(IHOKs) and on oral cancer cells representing two stages of oral cancer (HN4, 
HN12) based on a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay, Western blotting, cell cycle analysis, and nuclear 
staining
(72). 
 The both diol-containing compounds, 2a and 3, were the most cytotoxic of the 
sulfide series against V-79 cells in vitro (IC(90) = 2.1 microM and 1.9 
microM, respectively). A preliminary anticancer screening against P388 
leukemia showed that 2a is highly active in vivo as well
(73)
. 
 Allysulfur compounds from garlic are reported to reduce the incidence of  
Breast, Colon, Skin, Uterine and Lung cancers and to depress proliferation of  
tumor cells. 
 Allysulfur compounds contributes cell proliferation, although the  suppression 
of Anti-cancer activity 
(74)
. 
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Mercury 
 
 The drug Arkashara Rasa showed potent activity against pancreatic cancer 
cells (MIA-PaCa-2). LDH activity confirmed that AR was active against 
Pancreatic Cancercells 
(75)
. 
 
 The incineration process of theMercury and Sulfur macro particles are became 
very smaller and this may  be possible for devoid of toxicity and more potent 
in Anticancer therapy. 
 The results acquired from the in-vitro studies achieved via the HeLa cell lines 
reveals that theunique Siddha medicine Gowri Chinthamani Chendhooram 
(contains Mercury and Sulfur) have a potent Anticancer activity 
(76)
. 
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                                     4.   MATERIALS AND METHODS 
 
4.1. Preparation of the Drug 
  
Selection of Drug 
“Rasaparpam” is one of the Herbo mineral Siddha formulation which was indicated 
in the Siddha Sastric literature “Aathmarakchamirtham Ennum Vaithiya Saara 
Sangiragam” written by Kandhasamy Mudhaliyar(77). Hence the present study is 
taken to validate the scientific background behind this drug through the evaluation of 
toxicological, pharmacological and elucidation of structural components of the 
formulation Rasaparpam. 
Ingredients 
1. Vaalai Rasam (Purified Elemental Mercury)          35gms 
2. Gandhagam (Sulphur )              35gms 
3. Kattuulli – Indian squill (Urginea indica)          35gms 
Collection of crude drug: 
 Sulphur, Red sulphide of Mercury and Plumbago indica  were bought from 
R.N.Rajan Country raw drug shop at Parrys corner in Chennai, Tamilnadu. 
 The Kattuulli (Urginea indica) collected from the Kolli hills, Namakkal 
District. 
Identification and Authentication: 
 The raw materials were identified and authenticated by Botanist and 
Gunapadam experts, Government Siddha Medical College, Arumbakkam, 
Chennai. A specimen sample of each raw material has been kept in the 
department for future reference. (Reg.No:GSMCC/PGGM/0001-0003/14-17) 
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4.1.1. Purification of raw drug 
All the raw materials were purified as per the Siddha literature
(78) 
1.Vaalairasam (Processed Elemental Mercury) 
Kodiveli (Plumbaco zeylanica) roots were grounded well into a paste and smeared 
inside a mud pot and dried well. 7 palam (245gm) Lingam (Cinnabar) was placed in 
another mud pot and the mouth was covered with Kodiveli smeared pot. Then their 
mouths were sealed with mud pasted cloth. This apparatus was mounted in the earthen 
stove and burnt for 3 hours using fire wood. Purified elemental Mercury was obtained 
in the upper pot. Finally collected and used for the preparation of Rasaparpam. 
2. Sulphur 
Sulphur is placed in an Iron spoon. A small quantity of cow’s butter is added and the 
spoon is heated till the butter melts, this mixture is immersed in inclined position in 
cow’s milk. This procedure is repeated for 7 times to get purified Sulphur. Each time 
fresh milk is to be used.  
Sulphur mixed with ghee and heated. After it starts melting,  pour into the milk. 
Repeat the procedure for 7 times to get purified Sulphur.Each time fresh milk is to be 
used. 
3. Kattuulli - (Urginea indica)  
 The dust particles were removed. 
4.1.2. Preparation of the trial drug – Rasaparpam 
Procedure 
 Indian squaill and Sulphur – each 35gms were taken and placed in a 
stone mortar and ground well to get a paste. This is made as a pellet. 
 The pellet was kept in an earthen pot and  medicated oil was 
obtained by calcination method using the equipment – Kuzhi puda 
karuvi 
 This oil  got by Pudam (Kuzhi puda thylam) was added to Vaalai 
Rasam and kept exposed to  sun light for one day. And the substance 
was dried.  
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 This was  ground with the above oil and made as a pellet. 
 Bricks were taken and crushed into pieces to the size of betel nut.  
 Half of the brick pieces were spread in a round bottom earthen pot. 1 
padi (1.3lit) of salt was layered above the brick pieces and the pellet 
was kept over the salt. 
 The pot was covered with earthen dish and sealed with 8 layers of 
mud pasted cloth and heated using fire woods through high flame 
(Kaadakkini). 
 After that the covering dish was removed. The sublimate was 
obtained in the upper earthen dish. Finally Parpam was collected and 
ground well. 
 The Rasaparpamwas collected and kept in an air tight container. 
 The Rasaparpam was labelled as RP. 
Route of Administration: 
Oral  
      Dosage: 
Panavedai alavu (488 mg) 
      Adjuvant: 
Palm jaggery 
     Indication: 
 Tumor, Cervical cancer, Inguinal bubo, Abscess. 
                       Analytical study as per Siddha literature  
Siddhars explained many testing procedures and standardization methods for different 
kind of medicines. Under this chapter the colour, heaviness, appearance and sense on 
touch and other test are discussed. For a Siddha formulation these characters are 
required for standardization. 
1. Colour: 
Parpams are white in colour except Gold Parpam which is yellow colour. 
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        RP was taken and watch the colour  is observed in day light by naked eyes. 
This is displayed in Table No:7 
2. Floating on Water:  
This procedure is conducted to know about the density of the RP whether it is 
heavier or lesser than water. 
        A pinch of Parpam gently placed on the still surface of water in a vessel, did not 
sink immediately. It was found that the Rasaparpam particles floated over the surface 
of water indicated lightness of the trial drug.  
3. Lines on fingers: 
        Parpam in well prepared form should be as fine powder. When taken between 
thumb and index finger, the fine powder will fill up the lines of the finger print. A 
pinch of RPwas taken in between the thumb and index finger and rubbed. It was 
found that the RP entered into the lines of the finger and was not easily washed out 
from the lines, confirmed its fineness. 
 4. Irreversible reaction:  
         The well prepared Parpam does not get reversible to its metallic state when 
heated with a mixture of cane jaggery, hemp powder, ghee and honey. A pinch of RP 
was taken and mixed with cane jaggery, ghee and honey. It was observed that RP did 
not reverse to its metallic state.  
5. Tastelessness:  
         The well prepared Parpam should be completely tasteless. Presenceof any taste 
like sweet or bitter indicate incomplete preparation which needed another Calcination 
process. When a small amount of RP was kept on the tip of the tongue, no specific 
taste was found.  
6. Lustreless:  
If any shining particle is present in Parpam,it indicates that the Parpam is not 
manufactured properly and contains unchanged substances like minerals, metals and 
other toxic substances. There should be no shining particles present in the well 
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manufactured Parpam. The RPwas taken in a petri bowl and observed for any lustre 
in daylight through magnifying glass. No lustre was observed in the Parpam. 
The results were tabulated in Table no:7 
 
                                      4.2. Standardisation of the Drug 
Standardisation of drug means confirmation of its identity, determination of its quality 
and purity; detection of nature of adulterant by various parameters like morphological, 
microscopical, physical, chemical and biological evaluations
(79)
. 
Standardization of the drug Rasaparpam:   
Standardization of drugs helps to prove its identity and determination of its quality 
and potency. Standardization of the Herbo-mineral formulation is based on the 
qualitative and quantitative analysis through Physico-chemical investigations and 
instrumental analysis. The Physico-chemical analysis of the prepared Herbo-mineral 
drug have been done at Central Research Institute, Arumbakkam, Chennai and 
elemental analysis have been done at IIT, Chennai. (FTIR, SEM, ICP-OES, RAMAN 
Spectroscopy) 
4.2.1. Physico chemical analysis:  
Physico chemical studies of the trial drug have been done according to the WHO 
guidelines.  
pH value:  
Potentiometrically pH value was determined by a glass electrode and a suitable pH 
meter.  
Loss on Drying:  
Loss of weight expressed as percentage resulting from water by volatile matter of any 
kind that can be driven off under specified conditions. The test is carried out on a well 
mixed sample of the substance, if the substance is in the form of large crystals, reduce 
the size by rapid crushing to a powder form.  
The powdered drug was dried in the oven at 100- 105°C to constant weight.  
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Action on heat:  
A small amount of the RP was taken in a dry test tube and heated gently. If strong 
white fumes evolve indicate the presence of Carbonate.  
Flame test: 
A small amount of the RP was made into a paste with con. HCl in a watch glass and 
introduced into non-luminous part of the Bunsen flame. Appearance of bluish green 
flame indicates the presence of Copper.  
Ash Test:  
A filter paper is soaked into a mixture of RP and Cobalt nitrate solution and 
introduced into the Bunsen flame and ignited. Appearance of yellow colour flame 
indicates the presence of Sodium.  
Determination of Total Ash  
The residue remaining after incineration is the ash content of the drug.  
Total Ash Value: 
Total ash method is used to measure the total amount of material remaining after 
incineration
(80)
.  
Acid Soluble Ash:  
It is the residue obtained after boiling the total ash with dilute HCl and igniting the 
remaining insoluble matter.  
Water Soluble Ash:  
It is the difference in weight between total ash and residue after treatment of total ash 
with water.  
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4.2.2. Preliminary Basic and Acid Radical studies  
Preparation of extract
(81)
 
5gm of RP was weighed accurately and placed in a 250ml clean beaker and added 
with 50ml of distilled water. Then it was boiled well for about 20 minutes. Then it 
was cooled and filtered in a 1000ml volumetric flask and made up to 100ml distilled 
water. 
 
Table.No.4. Test for basic radicals 
 
 
 
 
 
 
 
PROCEDURE 
 
OBSERVATION 
 
INFERENCE 
 
Test for Potassium:  
A pinch of sample is treated with 2ml of 
sodium nitrate solution and then treated with 
2ml of cobalt nitrate in 30% of glacial acetic 
acid. 
 
Formation of Yellow 
colour precipitate 
Presence of 
Potassium 
Test for Calcium: 
Taken2 ml of extract in a clean test tube. Then 
acetic acid and potassium 
chromate solution were added 
 
No Yellow precipitate 
Presence of 
Calcium 
Test for Magnesium: 
2ml of extract was taken in a clean test tube, 
few drops of Magnason reagentwas added in 
drops. 
 
Formation of Blue  
colour precipitate 
 
Presence  of 
Magnesium 
Test for Ammonium: 
2mlof extract was taken in a test tube and 
added few ml of Nessler's reagent. 
 
 
 
 
 
 
Appearance of Brown 
colour 
 
 
 
Presence of 
Ammonium 
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Results were noted and tabulated in Table No:10 
 
PROCEDURE OBSERVATION INFERENCE 
Test for Sodium: 
2 pinches of Rasaparpam was mixed with HCl 
and made it into paste.  And introduced into 
the blue flame of Bunsen burner. 
 
Appearance of intense 
Yellow colour 
 
Presence of 
Sodium 
Test for Iron (Ferrous):   
2ml of extract was taken in a clean dried test 
tube and conc. HNO3 and ammonium 
thiocyanate were added. 
 
Appearance of Blood 
red colour 
 
Presence  of 
Ferrous iron 
Test for Zinc: 
   2 ml of the extract was taken in a test tube 
and Potassium ferro cyanide solution was 
added.  
 
 
Formation of White 
colour precipitate 
 
Presence  of 
Zinc 
Test for Aluminium: 
To the 2m1of the extract was taken in a test 
tube sodium hydroxide drops were added to it. 
 
White precipitate 
obtained 
 
Presence of 
Aluminium 
Test for Lead: 
2 ml of extract was taken in a test tube and 
added with 2ml of potassium iodide solution 
 
Formation of yellow 
colour precipitate 
 
Presence of 
Lead 
Test for Copper: 
    To a small portion of aextract dilute 
hydrochloric acid was added and then 
hydrogen sulphide gas is passed through the 
solution. 
 
Black precipitate 
 
Presence of 
Copper 
 
Test for Mercury: 
2m1 of the extract wastaken in a test tube and 
treated With 2ml of sodium hydroxide 
solution. 
 
Formation of Yellow 
precipitate 
 
 
Presence of 
Mercury 
 
 
Test for Arsenic:       
2m1 of the extract was taken in a test tube and 
treated with 2ml of sodium hydroxide solution. 
Formation of 
brownish red 
precipitate 
Presence of 
Arsenic 
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Table No:5 Test for acidic radical 
 
 
The bio-chemical analysis was done to identify the acid and basic radicals present in 
the RP 
The results were tabulated in Table No: 11 
 
 
PROCEDURE OBSERVATION INFERENCE 
Test for Sulphate: 
 2 ml of the extract was taken in clean, dry 
test tube and 5 % barium chloride solution 
was added to it. 
 
Formation of  white 
precipitate 
 
Presence of 
Sulphate 
Test for Chloride:  
The extract was taken in a test tube and 
then treated with Silver nitrate solution. 
 
Formation of  White 
precipitate 
 
Presence  of 
Chloride 
Test for Phosphate: 
The extract was taken in a test tube and 
treated with ammonium molybdate and 
conc. HNO3. 
 
Formation of Yellow 
precipitate 
 
Presence  of 
Phosphate 
Test for Carbonate :           
The substance was taken in a clean dry test 
tube and then treated with Conc. HCl. 
 
Formation  of 
Effervescence 
Presence  of 
Carbonate 
Test for fluoride &oxalate: 
2ml of extract was taken in a test tube and 
added with 2ml of dil.acetic acid, 2ml 
calcium chloride solution and then heated. 
 
Formation of cloudy 
appearance 
 
Presence of 
Fluoride & 
Oxalate 
Test for Nitrate: 
1gm of the Rasaparpam was heated with 
copper turnings andconcentrated H2SO4 
and observed the test tube vertically down. 
 
Characteristic changes 
 
Presence of 
Nitrate 
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4.2.3. Anti-microbial Load 
 
Availability of microbial load 
(82)
:  
Enumeration of bacteria by plate count – agar plating technique  
 The plate count technique was one of the most routinely used procedures because of 
the enumeration of viable cells by this method.   
Principle:  
This method was based on the principle that when material containing bacteria 
are cultured, every viable bacterium develops into a visible colony on a nutrient agar 
medium. The number of colonies therefore was the same as the number of organisms 
contained in the sample.  
Dilution:   
A small measured volume is mixed with a large volume of sterile water or saline 
called the diluent or dilution blank. Dilution is usually made in multiples of ten. A 
single dilution was calculated as follows:  
        Volume of the sample Dilution = Total volume of the sample and the diluent  
 Requirements: 
 Sample or Bacterial suspension  
 9 ml dilution blanks (7)   
 Sterile petri dishes (12)  
 Sterile 1 ml pipettes (7)  
 Nutrient agar medium (200 ml) Colony counter.   
 
Procedure: 
 Label the dilution blanks as 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, 10-7. 
 Prepare the initial dilution by adding 1 ml of the sample into a 9 ml dilution 
blank labelled10
-1
 thus diluting the original sample 10 times.  
 Mix the contents by rolling the tube back and forth between hands to obtain 
uniform distribution of organisms. 
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 From the first dilution transfer 1 ml of the suspension while in motion, to the 
dilution blank 10
-2
 with a sterile and fresh 1 ml pipette diluting the original 
specimen to 100 times.  
 From the 10-2 suspension, transfer 1 ml of suspension to 10-3 dilution blank 
with a fresh sterile pipette, thus diluting the original sample to 1000 times. 
 Repeat this procedure till the original sample has been diluted 10,000,000 
times using every time a fresh sterile pipette.  
 From the appropriate dilutions transfer 1ml of suspension while in motion, 
with the respective pipettes, to sterile petri dishes. Three petri dishes should  
be used for each dilution.  
 Add approximately 15 ml of the nutrient medium, melted and cooled to 45◦c, 
to each petri dish containing the diluted sample. Mix the contents of each dish 
by rotating gently to distribute the cells throughout the medium.  
 Allow the plates to solidity.  
 Incubate these plates in an inverted position for 24-48 hours at 37◦C.  
Observation 
Observe all the plates for the appearance of bacterial colonies. Count the number of 
colonies in the plates.  
Calculate the number of bacteria per ml of the original suspension as follows:  
             Number of colonies (average of 3 replates) Organisms per millimetre =  
Amount of plated × dilution  
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 4.2.4. Sophisticated Instrumental Analysis 
To know the test sample RP thoroughly – particle size, quantitative and qualitative 
values of chemical elements, molecular structure and their functional group, it 
underwent many analysis done by instruments.  
 FT-IR (Fourier Transform Infra-Red)  
Definition:  
FTIR offers quantitative and qualitative analysis for organic and inorganic samples. 
Fourier Transform Infrared Spectroscopy (FTIR) identifies chemical bonds in a 
molecule by producing an infrared absorption spectrum. The spectra produce a profile 
of the sample, a distinctive molecular fingerprint that can be used to screen and scan 
samples for many different components. FTIR is an effective analytical instrument for 
detecting functional groups
(83)
.  
Applications:  
 Quantitative Scans, Qualitative Scan Solids, Liquids, Gases  Organic Samples, 
Inorganic Samples  Unknown Identification  Impurities Screening  Formulation 
Pharmaceuticals.  
Instrument details  
It is the preferred method of infrared spectroscopy. FT-IR is an important and more 
advanced technique. It is used to identify the functional group, to determine the 
quality and consistency of the sample material and can determine the amount of 
compounds present in the sample. It is an excellent tool for quantitative analysis 
In FT-IR infrared is passed from a source through a sample. 
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  FTIR Instrument  
 
 
                                   Fig No. 12. FTIR Instrument 
 
                                  Fig No. 13. FTIR Mechanism  
Model   : Spectrum one: FT-IR Spectrometer Scan Range   :  MIR 450-4000 cm-1  
Resolution   :  1.0 cm-1 Sample required :  50 mg, solid or liquid.  
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This infrared is absorbed by the sample according to the chemical properties and 
some are transmitted. The spectrum that appears denotes the molecular absorption and 
transmission. It forms the molecular fingerprint of the sample. Like the finger print 
there is no two unique molecular structures producing the same infrared spectrum. It 
is recorded as the wavelength and the peaks seen in the spectrum indicates the amount 
of material present.  
FT-IR is the most advanced and the major advantage is its  
 Speed  
 Sensitivity  
 Mechanical  
 Simplicity  
 Internally Calibrated(84). 
SEM (Scanning electron microscope)  
Definition  
Scanning Electron Microscopy (SEM), also known as SEM analysis or SEM 
microscopy, is used very effectively in microanalysis and failure analysis of solid 
inorganic materials. Scanning electron microscopy is performed at high 
magnifications, generates high-resolution images and precisely measures very small 
features and objects
(85)
. 
SEM analysis applications  
The signals generated during SEM analysis produce a two-dimensional image and 
reveal information about the sample including:  
 External morphology (texture) Chemical composition (when used with EDS)  
Orientation of materials making up the sample  
The EDS component of the system is applied in conjunction with SEM analysis to:  
 Determine elements in or on the surface of the sample for qualitative information 
Measure elemental composition for semi-quantitative results Identify foreign 
substances that are not organic in nature and coatings on metal.  SEM Analysis with 
EDS – qualitative and semi-quantitative results  Magnification – from 5x to 300,000x  
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Sample Size – up to 200 mm (7.87 in.) in diameter and 80 mm (3.14 in.) in height. 
Materials analysed – solid inorganic materials including metals and minerals.  
 
 
 
 
 
 
 
 
 
 
Fig. No. 14. SEM Instrument 
 
Fig. No.15. SEM Mechanism 
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The SEM analysis process 
Scanning Electron Microscopy uses a focused beam of high-energy electrons to 
generate a variety of signals at the surface of solid specimens. In most SEM 
microscopy applications, data is collected over a selected area of the surface of the 
sample and a two-dimensional image is generated that displays spatial variations in 
properties including chemical characterization, texture and orientation of materials.  
The SEM is also capable of performing analyses of selected point locations on the 
sample. This approach is especially useful in qualitatively or semi-quantitatively 
determining chemical compositions, crystalline structure and crystal orientations.  
The EDS detector separates the characteristic X-rays of different elements into an 
energy spectrum and EDS system software is used to analyse the energy spectrum in 
order to determine the abundance of specific elements. A typical EDS spectrum is 
portrayed as a plot of X-ray counts vs. energy (in keV). Energy peaks correspond to 
the various elements in the sample.  
Energy Dispersive X-ray Spectroscopy can be used to find the chemical composition 
of materials down to a spot size of a few microns and to create element composition 
maps over a much broader raster area. Together, these capabilities provide 
fundamental compositional information for a wide variety of materials, including 
polymers.  
In scanning electron microscope high energy electron beam is focused through a 
probe towards the sample material. Variety of signals was produced on interaction 
with the surface of the sample. This results in the emission of electrons or photons and 
it is collected by an appropriate detector
(86)
.  
The types of signal produced by a scanning electron microscope include  
      Secondary electrons  back scattered electrons characteristic x-rays, light  specimen 
current Transmitted electrons.  
FT-Raman/IR spectrophotometer 
(87) 
This instrument is used to determine of molecular structure or to indentify 
materials by infrared spectroscopy and Raman spectroscopy. Generally: Fourier 
transformation Raman spectroscopy is suitable to investigate chemical composition 
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and structural properties of solid and liquid (polarization measurements) samples. The 
technique is non-destructive with no sample preparation requirement.  
Specifically Dedicated BioRad FT-Raman spectrometer with near-IR excitation laser 
(1064 nm). The near-IR excitation is a requirement for biological samples allowing 
non-destructive spectra collection with reduced fluorescence. 
The Raman scattering technique is a vibrational molecular spectroscopy which 
derives from an  inelastic light scattering process. With Raman spectroscopy, a laser 
photon is scattered by a sample molecule and loses (or gains) energy during the 
process. The amount of energy lost is seen as a change in energy (wavelength) of the 
irradiating photon. This energy loss is characteristic for a particular bond in the 
molecule. Raman can best be thought of as producing a precise spectral fingerprint, 
unique to a molecule or indeed and individual molecular structure. 
The RASA PARPAM obtained after sublimation process, shows 6 peaks   respectively. 
The results are shown in Table.No.14. 
                             
 
                                         Fig.No. 16. FT-Raman spectrometer 
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ICPOES  (Inductively Coupled Plasma Optic Emission Spectrometry)  
                             
 
                                    Fig No.17. ICP-OES Instrument 
                           
 
                               Fig No:18. ICP-OES Mechanism 
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Manufacturer: Perkin Elmer Model 
 Optima 5300 DV ICP-OES Inductively Coupled Plasma Spectrometer (ICP) 
Principle: An aqueous sample is converted to aerosols via a nebulizer. The aerosols 
are transported to the inductively coupled plasma which is a high temperature zone 
(8,000– 10,000ºC). The analysts are heated (excited) in different (atomic and/or ionic) 
states and produce characteristic optical emissions (lights). These releases are 
separated based on their respective wavelengths and their strengths are measured 
(spectrometry). The intensities are proportional to the concentrations of analyses in 
the aqueous sample.  
The quantification is an external multipoint linear standardization by comparing the 
emission intensity of an unknown sample with that of a standard sample. Multi-
element calibration standard solutions are prepared from single- and multi element 
primary standard solutions. With respect to other kinds of analysis where chemical 
speciation is relevant (such as the concentration of ferrous iron or Ferric Iron), only 
total essential concentration is analysed by ICP-OES
(88)
.  
Application 
The analysis of major and minor elements in solution samples. 
Objectives 
 
 Determine elemental concentrations of different metals. 
 Learn principles and operation of the ICP-OES instrument 
 
 Develop and put on a method for the ICP-OES sample analysis 
 Enhance the instrumental conditions for the analysis of different elements 
Probes the outer electronic structure of atoms. 
Mechanism: 
In plasma emission spectroscopy (OES), a sample solution is presented into the core 
of Inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C. At this temperature all elements become thermally excited 
and emit light at their characteristic wavelengths.  
This light is collected by the spectrometer and passes through a diffraction grating 
that serves to resolve the light into a spectrum of its essential wavelengths. Within the 
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spectrometer, this deflected light is then collected by wavelength and amplified to 
yield an strength of  measurement that can be converted to an elemental concentration 
by comparison with standardizationvalues. The Inductively coupled plasma optical 
emission spectrometric (ICP-OES) analysis was done in SAIF, IIT MADRAS, 
Chennai-36 using Perkin Elmer Optima 5300 DV.  
Sample preparation:  
Inductively Coupled Plasma Spectroscopy techniques are the so-called "wet" 
sampling methods whereby samples are introduced in liquid form for analysis. 100 
mg RP was occupied in a clean, dry test tube. To this, 3 ml Nitric acid was added and 
mixed well and allowed for few minutes until the reactions were completed. And 
then, 25 ml of Refined water, was added to prepare digested solution.  
The digested sample solution was shifted into plastic containers and labelled properly. 
It was completed in Bio-chemistry lab, Govt. Siddha Medical College, Chennai-106. 
 
4.2.5. TOXICOLOGICAL STUDIES 
Acute oral toxicity – OECD guidelines – 423  
Acute toxicity study was carried out as per OECD guideline (Organization for 
Economic Co - operation and Development, Guideline-423
(89)
.  
IAEC No: IAEC/XLVIII/03/CLBMCP/2016,C.L.BaidMetha College of Pharmacy, 
Thoraipakkam, Chennai.  
Introduction  
 The acute toxic class method is a stepwise procedure with the use of 3 animals 
of a single sex per step. 
 Depending on the mortality and/or the moribund status of the animals, on 
average 2-4 steps may be necessary to allow  judgement on the acute toxicity 
of the test substance.  
 This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods.  
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 The acute toxic class method is based on biometric evaluations with fixed 
doses, adequately separated to enable a substance to be ranked for 
classification purposes and hazard assessment.  
 In principle, the method is not intended to allow the calculation of a precise 
LD50, but does allow for the determination of defined exposure ranges where 
lethality is expected since death of a proportion of the animals is still the major 
endpoint of this test.  
 The method allows for the determination of an LD50 value only when at least 
two doses result in mortality higher than 0% and lower than 100%.  
 The use of a selection of pre-defined doses, regardless of test substance, with 
classification explicitly tied to number of animals observed in different states 
improves the opportunity for laboratory to laboratory reporting consistency 
and repeatability.  
Principle of the Test  
It is the principle of the test that based on a stepwise procedure with the use of a 
minimum number of animals per step, sufficient information is obtained on the acute 
toxicity of the test substance to enable its classification. The substance is administered 
orally to a group of experimental animals at one of the defined doses. The substance is 
tested using a stepwise procedure, each step using three animals of a single sex. 
Absence or presence of compound-related mortality of the animals dosed at one step 
will determine the next step, i.e. 
 no further testing is needed 
 dosing of three additional animals, with the same dose  
 dosing of three additional animals at the next higher or the next 
lower dose level. The method will enable a judgment with respect to 
classifying the test substance to one of a series of toxicity classes. 
Methodology 
Selection of Animal Species  
The preferred rodent species is the wistar albino rat, although other rodent species 
may be used. Healthy young adult animals are commonly used laboratory strains 
should be employed. Females should be nulliparous and non-pregnant. Each animal, 
at the commencement of its dosing, should be between 6 to 8 weeks old and the 
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weight (150-200gm) should fall in an interval within±20 % of the mean weight of any 
previously dosed animals.  
Housing and Feeding Conditions 
The temperature in the experimental animal room should be 22ºC + 3ºC.  Although 
the relative humidity should be at least 30% and preferably not exceed 70% other than 
during room cleaning the aim should be 50-60%. Lighting should be artificial, the 
sequence being 12 hours light, 12 hours dark. For feeding, conventional laboratory 
diets may be used with an unlimited supply of drinking water. Animals may be group-
caged by dose, but the number of animals per cage must not interfere with clear 
observations of each animal
(90)
. 
Preparation of Animals 
The animals are randomly selected, marked to permit individual identification, and 
kept in their cages for at least 7 days prior to dosing to allow for acclimatization to the 
laboratory conditions 
Test Animals and Test Conditions:  
Sexually mature Female Wistar albino rats (150-200 gm) were obtained fromKings 
institute, Chennai.All the animals were kept under standard environmental condition 
(22±3°C).  The animals had free access to water and standard pellet diet (Sai meera 
foods, Bangalore). 
Preparation for Acute Toxicity Studies 
 Rats were deprived of food overnight (but not water 16-18 h) prior to administration 
of the, Rasa Parpam. The principles of laboratory animal care were followed and the 
Institutional Animal Ethical Committee approved the use of the animals and the study 
design. 
Test Substance  :  RASA PARPAM 
Animal Source  :  Kings institute, Chennai.   
Animals   :  Wistar AlbinoRats (Female-3+3) 
Age    :  6-8 weeks 
Body Weight on Day 0 : 150-200gm. 
Acclimatization  :  Seven days prior to dosing. 
Veterinary examination : Prior and at the end of the acclimatization period. 
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Identification of animals : By cage number, animal number and individual   
      marking by using Picric acid. 
Numberofanimals  :  3 Female/group,  
Routeofadministration :   Oral  
Diet    : Pellet feed supplied by Sai meera foods Pvt 
Ltd,Bangalore 
Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages  
      provided with bedding of husk. 
Housing temperature : Between 22ºC + 3ºC.  
Relative humidity  : Between 30% and 70%, 
Air changes    : 10 to 15 per hour and  
Dark and light cycle   : 12:12 hours. 
Duration of the study : 14 Days 
 
Administration of Doses 
Rasa Parpamwas suspended in water and administered to the groups of wistar albino 
rats in a single oral dose by gavage using a feeding needle. The control group received 
an equal volume of the vehicle. Animals were fasted 12 hours prior to dosing. 
Following the period of fasting, the animals were weighed and then the test substance 
was administered. Three Female animals are used for each group. The dose level of 
10µg/kg, 1 mg/kg and 2 mg/kgbody weight was administered stepwise.  
After the substance has been administered, food was withheld for a further 3-4 hours. 
The principle of laboratory animal care was followed. Observations were made and 
recorded systematically and continuously as per the guideline after substance 
administration. The visual observations included skin changes, mobility, aggressively, 
sensitivity to sound and pain, as well as respiratory movements.Finally, the number of 
survivors was noted after 24 hrs and these animals were then monitered for a further 
14 days and observations made daily. The toxicological effect was assessed on the 
basis of mortality. 
Observations 
Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the 
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first 4 hours, and daily thereafter, for a total of 14 days, except where they need to be 
removed from the study and humanely killed for animal welfare reasons or are found 
dead.  
It should be determined by the toxic reactions, time of onset and length of recovery 
period, and may thus be extended when considered necessary. The times at which 
signs of toxicity appear and disappear are important, especially if there is a tendency 
for toxic signs to be delayed. All observations are systematically recorded with 
individual records being maintained for each animal. 
Observations include changes in skin and fur, eyes and mucous membranes, and also 
respiratory, circulatory, autonomic and central nervous systems and somatomotor 
activity and behavior pattern. Attention was directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. The principles and 
criteria summarized in the Humane Endpoints Guidance Document taken into 
consideration. Animals found in a moribund condition and animals showing severe 
pain or enduring signs of severe distress was humanly killed. When animals are killed 
for humanreasons or found dead, the time of death was recorded. 
Behaviour: 
The animals will be observed closely for behaviour in the first four hours which  
includes abnormal gait, aggressiveness, exophthalmos, ptosis, akinesia, catalepsy, 
convolusion, excitation, head twitches, lacrimation, loss of corneal reflex, loss of 
traction, piloerection  reactivity of touch, salivation, scratching, sedation, chewing,  
head movements, sniffing, straub, tremor and writhes, diarrhea, leathery, sleep and 
coma. 
Body Weight:  
Individual weight of animals was determined before the test substance was 
administered and weights will be recorded at day 1, 7, and 14 of the study. Weight 
changes were calculated and recorded. At the end of the test, surviving animals were 
weighed and humanly killed. 
Food and water Consumption 
 Food and water consumed per animal was calculated for control and the treated dose 
groups.  
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Mortality: 
Animals were observed for mortality throughout the entire period. 
Data and reporting  
All the data were summarised in tabular form showing the animals used, number of 
animals displaying signs of toxicity, the number animals found dead during the test or 
killed for humane reasons, a description and the time course of toxic effects and 
reversibility, and necropsy findings.  
Test substance and Vehicle In order to ensure the uniformity in drug distribution in 
the medium the suspension was made by mixing Rasaparpam with 2% CMC solution 
and it was found suitable for dose accuracy. Justification for choice of vehicle.  
The vehicle selected as per the standard guideline is pharmacologically inert and easy 
to employ for new drug development and evaluation technique
(91)
. (Schlede E., 
Mischke U.,etal)  
28-Days Repeated Oral Toxicity Study of 
Rasa Parpam 
 
Test Substance  : RASA PARPAM 
Animal Source  : Kings institute, Chennai.   
Animals   : Wister Albino Rats (Male -24, and Female-24) 
Age    : 6-8 weeks 
Body Weight  :150-200gm. 
Acclimatization  : Seven days prior to dose. 
Veterinary examination : Prior and at the end of the acclimatization period. 
Identification of animals : Bycage number, animal number   and    individual  
   marking by using    Picric acid 
Diet    : Pellet feed supplied by Sai meera foods Pvt Ltd,       
        Bangalore 
Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages  
         provided with bedding of husk. 
Housing temperature : Between 22ºC + 3ºC.  
Relative humidity  : Between 30% and 70%, 
Air changes    : 10 to 15 per hour  
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Dark and light cycle   : 12:12 hours. 
Duration of the study : 28 Days. 
Table No.6. Animal groups 
GROUPS No.of Rats 
Group I Vehicle control (water) 12 (6 male, 6 female) 
Group II Rasa Parpam (10 µg/kg) 12 (6 male, 6 female) 
Group III Rasa Parpam (100 mg/kg) 12 (6 male, 6 female) 
Group IV Rasa Parpam 200mg/kg 12 (6 male, 6 female) 
 
 
Methodology
(92) 
Randomization, Numbering and Grouping of Animals 
48 Wistar Albino Rats (24M + 24F) were selected and divided into 4 groups. 
Each group consist of 12 animals (Male -6, and Female-6). First group treated as a 
control and other three group were treated with test drug (low, mid, high) for  28 days. 
Animals were allowed acclimatization period of 7 days to laboratory conditions prior 
to the initiation of treatment. Each animal was marked with picric acid. The females 
were nulliparous and non-pregnant. 
Justification for Dose Selection: 
         As per OECD guideline three dose levels were selected for the study. They are 
low dose (X), mid dose dose (100X), high dose (200X). X is calculated by 
multiplying the therapeutic dose (30mg) and the body surface area of the rat (0.018). 
i.e X dose is 8.784 µg/animal, (rounded to 10 µg), 100X dose is 1mg/animal,200X 
dose is 2mg/animal. 
Preparation and Administration of Dose: 
Rasa Parpam suspended in with water, It was administered to animals at the 
dose levels of X, 100X, 200X. The test substance suspensions were freshly prepared 
every two days once for 28 days. The control animals were administered vehicle only. 
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The drug was administered orally by using oral gavage oncedaily for 28 consecutive 
days. 
Observations 
Experimental animals were kept under observation throughout the course of 
study for the following: 
Body Weight: 
Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study. 
Food and water Consumption: 
Food and water consumed per animal was calculated for control and the 
treated dose groups.  
Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
Mortality: 
All animals were observed twice daily for mortality during entire course of    
study. 
Necropsy: 
All the animals were sacrificed on day 29. Necropsy of all animals was carried out 
and the weights of the organs including liver, kidneys, spleen, brain, heart, and lungs 
were recorded.  
The relative organ weight of each animal was then calculated as follow, 
                                                        Absolute organ weight (g) 
  Relative organ weight (g) =_____________________________________ ×100                                                      
                                                  Body weight of animal on sacrifice day (g)  
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Laboratory Investigations: 
Following laboratory investigations were carried out on day 29 in animals fasted over-
night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for Hematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
Haematological Investigations: 
Haematological parameters were determined using Haematologyanalyzer.  
Biochemical Investigations:  
 Biochemical parameters were determined using auto-analyzer. 
Histopathology:  
Control and highest dose group animals will be initially subjected to histopathological 
investigations. If any abnormality found in the highest dose group than the low, then 
the mid dose group will also be examined. Organs will be collected from all animals 
and preserved in 10% buffered neutral formalin for 24 h and washed in running water 
for 24 h.  The organ sliced 5 or 6µm sections and were dehydrated in an auto 
technicon and then cleared in benzene to remove absolute alcohol. Embedding was 
done by passing the cleared samples through three cups containing molten paraffin at 
50°C and then in a cubical block of paraffin made by the “L” moulds. It was followed 
by microtome and the slides were stained withHaematoxylin-eosin red. 
Statistical analysis:  
Findings such as body weight changes, water and food consumption,hematology and 
blood chemistry were subjected to One-way ANOVA followed by dunnett test using a 
computer software  Graph pad  version 7. 
All data were summarized in tabular form, (Table.No.19 to Table No.23 ) 
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4.3. PHARMACOLOGICAL ACTIVITY 
4.3.1. Pharmacological activity in-vitro Anticancer activity 
determination by MTT assay  
HeLa (cervical cancer cells) was initially procured from National Centre for Cell 
Sciences (NCCS), Pune, India and maintained Dulbeccos modified Eagles medium 
(Gibco, Invitrogen).  
 The HeLa cell line was cultured in 25 cm2 tissue culture flask with DMEM 
supplemented with 10% FBS L-glutamine, sodium bicarbonate and antibiotic solution 
containing: Penicillin (100U/ml), Streptomycin (100µg/ml), and Amphotericin B 
(2.5µg/ml). Cultured cell lines were kept at 37ºC in a humidified 5% CO2 incubator 
(NBS Eppendorf, Germany).  
The viability of cells was evaluated by direct observation of cells by Inverted phase 
contrast microscope and followed by MTT (4,5-dimethylthiazol-2-yl) assay method.  
 Cells seeding in 96 well plate: Two days old confluent monolayer of cells were 
trypsinized and the cells were suspended in 10% growth medium, 100µl cell 
suspension (5x104 cells/well) was seeded in 96 well tissue culture plate and incubated 
at 37ºC in a humidified 5% CO2 incubator.  
 Preparation of plant extracts and compound stock: 1 mg of sample/compound was 
added to 1ml of DMEM and dissolved completely by cyclomixer. After that the 
solution was filtered through 0.22 µm Millipore syringe filter to ensure the sterility.  
 Cytotoxicity Evaluation:  
After 24 hours the growth medium was removed, freshly prepared each plant extracts 
in 5% DMEM were five times serially diluted by two-fold dilution (100µg, 50µg, 
25µg, 12.5µg, 6.25µg in 100µl of 5% MEM) and each concentration of 100µl were 
added in triplicates to the respective wells and incubated at 37ºC in a humidified 5% 
CO2 incubator.  
Cytotoxicity Assay by Direct Microscopic observation: Entire plate was observed at 
an interval of each 24 hours; up to 72 hours in an inverted phase contrast tissue 
culture microscope (Olympus CKX41 with Optika Pro5 CCD camera) and 
microscopic observation were recorded as images.   
 MATERIALS & METHODS 
 
ANTI –CANCER ACTIVITY OF RASAPARPAM Page 94 
 
Any detectable changes in the morphology of the cells, such as rounding or shrinking 
of cells, granulation and vacuolization in the cytoplasm of the cells were considered 
as indicators of cytotoxicity.  
Cytotoxicity Assay by MTT Method: Fifteen mg of MTT (Sigma, M-5655) was 
reconstituted in 3 ml PBS until completely dissolved and sterilized by filter 
sterilization.  
After 24 hours of incubation period, the sample content in wells were removed and 
30µl of reconstituted MTT solution was added to all test and cell control wells, the 
plate was gently shaken well, then incubated at 37ºC in a humidified 5% CO2 
incubator for 4 hours.  
After the incubation period, the supernatant was removed and 200µl of MTT 
Solubilisation Solution DMSO was added and the wells were mixed gently by 
pipetting up and down in order to solubilise the formazan crystals.  
The absorbance values were measured by using microplate reader at a wavelength of 
540 nm (Laura B. Talarico et al., 2004).  
 The percentage of growth inhibition was calculated using the formula:  
  
 Mean OD Samples 
  
 
 % of viability = 
   
x  100    
Mean OD of control group     
 
 
                                             4.3.2. Anti- tumor activity 
Anti-tumor activity Cell culture  
The human cervical carcinoma a cell lines, HeLa and SiHa, used in the study was 
obtained from National Centre for Cell Science (NCCS), Pune, India. The cells were 
grown in DMEM containing 2m ML-glutamine supplemented with 10% fetal bovine 
serum and100U/ml of penicillin-streptomycin. The cellswere incubated in a 
humidified 5% CO2 incubator at37°C.  
% of viability =  x   100  
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Cell growth analysis  
HeLa and SiHa cells were seeded at a density of 1 × 105 cells/ml in24-well plates in 
triplicates.  Next day, the cells were dosed with different concentrations of RP 
(1.25,2.5 and 5.0ȝµg/ml) and grown for 6, 12 and 24 h. The cells were harvested and 
counted for viability using trypan blue dye exclusion method.  
Colony formation assay  
The cells were plated at a seeding density of 1 × 103 cells/ ml in 6-well plates. After 
24 h, the cells were exposed to various concentrations of RP: 0, 10, 20, 40, and 80 ȝg/ 
ml. Plates were incubated at 37°C in a5% CO2 incubator for one week. This was 
followed by fixing the colonies with 4% paraformaldehyde and staining 
with0.5%crystal violet. The colonies were photographed with Sony DSC-S75 cyber-
shotcamera
(90)
.  
Soft agar assay Control HeLa and SiHa cells (5×103cells/ml) as well as cells treated 
with different  concentrations of RP (10-80 ȝg/ml) were mixed at 40°C with 
0.35%agarose (DNA grade, GIBCOBRL, CA, USA) in culture medium and gelled at 
room temperature for 20min over a previously gelled layer of 0.5% agarose in culture 
medium in 6-wellplates.  
After incubation for 10days, colonies were photographed directly using an 
Axiovert200M microscope (CarlZeiss, Germany) and counted.  
Measurement of Apoptosis  
The cells were plated at a seeding density of 5 × 105 cells/ well and treated with 
different concentrations of RP (0-80 ȝg/ml). After 24 h of treatment, the cells were 
harvested and washed with PBS twice.  Cells were stained with Annexin VFITC 
following the manufacturer's instructions (Annexin V-FITC apoptosis kit #3, Invitro- 
gen) and analyzed for apoptosis by FACS using Cell Quest Software.  
Statistical analysis  
All experiments were performed in triplicates and repeated at least five times and the 
data were presented as mean ±SD. Statistical analysis was conducted with the Sigma 
Stat 3.5program (Systat Software, Inc.) using one- way ANOVA. The level used for 
comparisons was Į=0.05.  
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                                       4.3.3. Anti-oxidant activity  
DPPH assay (2, 2-diphenyl-1-picrylhydrazyl)  
  The radical scavenging activity of RP extracts was determined by using DPPH assay 
according to Change tal.(2001). 
The decrease in the absorption of the DPPH solution after the addition of an anti-
oxidant was measured at 517nm.Ascorbic acid (10mg/ml DMSO) was used as 
reference.  
 Principle  
 1,1Diphenyl 2- PicrylHydrazyl is a stable (in powder form) free radical with red 
color which turns yellow when scavenged.  
The DPPH assay uses this character to show free radical scavenging activity. The 
scavenging reaction between (DPPH) and an anti-oxidant (H- A) can be written as,  
 (DPPH)+ (H-A) DPPH-H +(A)  
 Anti-oxidants react with DPPH and reduce it to DPPH-H and as consequence the 
absorbance decreases.  
The degree of discoloration indicates the scavenging potential of the anti-oxidant 
compounds or extracts in terms of hydrogen donating ability.  
Reagent preparation  
 0.1mM DPPH solution was prepared by dissolving 4mg of DPPH in 100mlof 
ethanol.  
Working procedure  
 Different volumes (1.25-20µg/µl) of RP extracts were made up to 40µl with DMSO 
and 2.96ml DPPH (0.1mM) solution was added.  
Their action mixture was incubated in dark condition at room temperature for 
20min.After 20min, the absorbance of the mixture was read at 517 nm. 3ml of DPPH 
was taken as control.  
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The % radical scavenging activity of the RP extracts was calculated using the follow                                                                                        
 
Control- test 
% inhibition =        _____________________________ x 100 
Contol 
 
 
 
Ingredients of Rasaparpam 
 
 
 
 
 
 
 
 
Fig.No.7. Purified Elemental Mercury                                       Fig.No.8.  Sulfur 
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                                   Fig.No. 7 – 9 Showing ingredients of Rasaparpam 
                                          Preparation of VaalaiRasam 
 
 
 
 
 
 
 
 
(A)  Herbal coating                                                             (B) Ignition  
   
 
 
 
  
  
  
 (C)  After ignition                                                   (D) Collecting Vaalairasam 
                        
 
 
 
 
VaalaiRasam 
 
Fig.No:10. A, B,C,D  Showing  preparation of Vaalairasam 
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                Fig.No:11. A – G  Shows  preparation of Rasa Parpam 
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   5.RESULTS AND DISCUSSION 
 
One of the Siddha Herbo mineral formulation of “Rasaparpam” had been exposed to 
scientific validates. Literary collection, Physicochemical and elemental analysis, 
toxicological studies and pharmacological studies are done to justify the anticancer 
activity of RP against cervical cancer. 
From Review of literature 
Discussion on Gunapadamreview 
 The poem for general properties of processed quicksilver directly indicates its 
anti-cancer nature. 
 As per Siddha classical text, Sulfur by its herbo-mineral formulation indicates 
anti-cancer property. 
 The plant Urgineaindicais used to treat cancer.  
Discussion on modern drug review 
 Mercury helps to destroy the cancer cells and reduces the tumor growth(93). 
 Mercuric chloride has cyto toxiceffects(94). 
 Sulfur contains anti-cancer property(95) 
 Urgineaindica contains anti- oxidant property(96). 
Discussion on pharmaceutical review 
Parpam: 
 100 years of shelf life denotes its long time efficacy. 
 Being very fine particles in nature, increases the therapeutic effect. 
Discussion of pharmacological review 
The cell lines for anticancer activity were HeLa and SiHa. They are the genomes of 
HPV 16 and HPV 18 respectively. These HPV 16 and HPV 18 are responsible for 
93% of Cancer cervix
(97)
. 
So, the analysis of pharmacological activity through HeLa and SiHa cell lines are the  
novel methods for validation which proves the effective anticancer activity of RP. 
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Discussion on materials and methods 
 The selection of trial drug was taken from the book 
AathmaRakshamirthamEnnumVaithiyaSaaraSangiragam, Written 
byKandhasamyMudhaliyar, wasapproved by the Department of AYUSH as 
Per Classical Siddha literature. 
 The ingredients were bought from the authenticated vender and they were 
identified and authenticated by the experts in Post Graduate Department 
Gunapadam, GSMC, Chennai. So the ingredients were perfect and original. 
 The preparation of medicine was done at the well-equipped lab of the Post 
Graduate Department Gunapadam. So the principles of GMP were adhered 
during the process. 
 The analytical parameters were conducted at registered and licensed 
laboratories only. Thus the result of Rasaparpam under various analytical 
procedures shows the accuracy of RP. 
 The Siddha Herbo-mineral formulation Rasaparpam had been subjected to 
variousstudies for its scientific validation and safety assessment. Literary 
collections, physicochemical and Elemental analysis, Toxicological study, 
Pharmacological studies are done to prove its efficacy. 
Table No.7.Results of Siddha Standardization 
S.No  Parameters  Results of RP Results of SP 
1 Colour White  White 
2 Floating on water Floats on water Floats on water 
3 Finger print test Impinged in the furrow of 
fingers 
Impinged in the 
furrow of the fingers 
4 Luster  Lusterless Lusterless  
5 Taste  No specific taste No specific taste 
 
Interpretation 
Colour:  
Rasaparpam is white in colour. The absence of shining denotes that it is free from  
metals. 
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Floating on water:  
Rasaparpamfloats on water because of  its less specific gravity.  It denotes the 
lightness of the drug,So, it posesses the property of Parpam. 
Finger print test: 
Rasaparpam impinged on the lines of the finger. It is denotes the particles are fine and 
it is in micro size. 
Luster : 
No luster was observed in the Rasaparpam. It is due to the change of specific metallic 
character of raw material after incineration. It  denotes that it is well manufactured. 
Taste : 
No specific taste in the Rasaparpam. It is due to the change of specific metallic 
character of raw material after incineration. 
Table No.8.Physical characterization of Rasaparpam 
 
S.No Parameters Result 
1 Colour White 
2 State of the drug Powder  
3 Consistency  Fine powder 
4 Solubility   
 Distilled water Sparingly soluble 
Ethanol  Sparingly soluble 
Methanol  Sparingly soluble 
 Propylene Glycol Not soluble 
Petrolium ether Not soluble 
Tolune Not soluble 
Chloroform Soluble 
Carbon tetra chloride Soluble 
Xylene Not soluble 
5 Sense on touch Fine  
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S.No Parameters Result 
6 Sense on taste Tasteless  
7 Sense of smell No significant smell is 
observed 
 
Physicochemical Analysis 
Table No.9.Results of Physicochemical Analysis 
S.No Parameters Result 
1 Loss on drying (at 105◦C) 1.0% 
2 Total ash 99% 
3 Water soluble ash 5.40% 
4 Acid insoluble ash 3.65% 
5 p
H 
6.9 
 
Interpretation 
Solubility 
 
 Solubility  is  the  major factor  that  controls  the  bioavailability  of  a  
drugsubstance. 
 
 It is useful to determine the form of drug and processing of its dosage form. 
 
 The most frequent causes of low oral bioavailability are attributed to poor 
solubility and low permeability
(98)
. 
 
 Rasaparpamis soluble in major solvents and sparingly soluble in some 
solvents.This proves its efficiency of solubility in the stomach indirectly, 
increasing the bio availability. 
 
P
H
 value 
Rasaparpamshows acidic P
H
. 
 The PH level plays a role in enzyme activity by maintaining the internal 
environment thus regulating the homeostasis. 
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 It is also an important factor for drug absorption (99). Because of the acidic 
nature, the drug is more readily absorbed in an acidic medium like stomach 
which enhances the bioavailability of the drug. 
Loss on drying 
 
 Loss on drying (LOD) gives the total amount of volatile content and moisture 
(water) present in the drug. 
 
 The stability of a drug and its shelf-life are dependent on moisture 
content. Moisture increase can adversely affect the active ingredient. 
 
 Low moisture content- drug could get maximum stability and better shelf life. 
  
 Since the drug has low loss on drying, the moisture content is less which is 
suitable for medicine preparation. 
 
Ash values (Total Ash value) 
 
 
Low total Ash value indicates the trial drug contains plant organic derivatives. It is 
not subjected to calcination process. 
Acid insoluble ash 
Lower the acid insoluble value better will be the drug quality
(100)
. The drug 
ensures a low value of acid insoluble ash indicating that the preparation did not 
contain any sand, dust and stones. 
 
Water soluble ash 
Decreased water soluble ash value (5.40 %) indicates easy facilitation of 
diffusion and osmosis mechanisms. 
Biochemical Analysis 
Table No.10. Results of Basic radicals 
S.No Parameters Result 
1 Test for Potassium Negative  
2 Test for Calcium Positive  
3 Test for Magnesium  Positive  
4 Test for Ammonium Negative  
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S.No Parameters Result 
5 Test for Sodium Negative  
6 Test for Iron (ferrous) Negative  
7 Test for Zinc Positive  
8 Test for Aluminium Positive  
9 Test for Lead Negative  
10 Test for Copper  Negative  
11 Test for Mercury Positive  
12 Test for Arsenic Negative  
 
The biochemical analysis for basic radicals of RP shows the presence of Calcium, 
Magnesium, Zinc, Aluminium and Mercury. 
Table No.11.Results of Acid Radicals 
S.No Parameters Result 
1 Test for Sulphate Positive  
2 Test for Chloride positive  
3 Test for Phospate Negative  
4 Test for Carbonate Negative  
5 Test for Fluoride & 
Oxalate 
Negative  
6 Test for Nitrate Negative  
 
The bio chemical analysis for acid radical of RP shows the presence of Sulphate  and 
Chloride. 
Interpretation  
The presence of these radicals helpsRPfor its therapeutic effect.  
 Zinc is needed for immune function, wound healing and blood clotting. 
 Mercury helps to destroy the cancercells and reduces the tumor growth 
 Mercuric chloride has cyto toxic effects 
 Sulphate contains anti-cancer property. 
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Anti- microbial load 
Availability of bacterial and fungal load in Rasaparpam 
Table No.12. Bacterial and Fungal dilution 
Micobes Dilution  Result  
Bacteria  10
-4 
7 
Bacteria  10
-6 
6 
Fungi  10
-3 
Nil  
Fungi  10
-2 
Nil  
 
Interpretation  
 This is one of the Siddhaherbo mineral formulations which are prepared by 
using plant materials that are prone to contamination. The contamination of 
herbal drugs by micro organism not only cause bio deterioration but also 
reduces the efficacy of drugs. 
 The toxic effect produced by microbes makes the herbal drugs to give no 
response for human consumption because the contaminated drug may develop 
unwanted disease instead of disease being cured. 
FTIR(Fourier transform infrared spectroscopy) 
 
 Fig.No.19.FTIR – waves of RP.   
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Table.13.FTIR-  results of RP 
Frequency, cm
-1 
Bond Functional Group 
3425 
O-H Stretch,H-
bonded 
Alcohol, Phenols 
1638 N-H bend 1
◦
 amines 
1184 C-H wag (-CH2X) Alkyl halides 
1103 C-O Stretch 
Carboxylic acids, 
esters,ether 
676 C-H “oop” Aromatics  
618 -C=C-H:C-H bend Alkynes 
602 C-Br stretch Alkyl halides 
587 C-Cl stretch Alkyl halides 
 
Interpretation  
 The wave numbers from 4000cm-1 to 1500cm-1 gives details for 
identification of functional group. 
 
 The wave number from 1500cm -1 to 400 cm-1 provides particulars about 
molecular fingerprint. 
 
 The above result showed the presence of functional group like Phenol, 
Alcohols, Alkynes, Amines, Carboxylic acids, Esters, Ether and Alkyl halides  
inRasaparpam. 
 
 They may be responsible for the presence of anticancer action of RP in 
cervical cancer. 
Alcohols 
 OH group of RPhas higherr potential towards inhibitory activity against 
microorganism. 
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Phenols 
 Phenols of RP possess highly Anti-Oxidant property which enchances its 
effect against the disease. 
 Phenolic acid components take part in important roles in the control of cancer 
and other diseases. 
 Currently great awareness is on the effect of phenols  due to their anti-
oxidative and possibeanti cancer activities. 
 Free radicals react easily with phenols to abstract the hydrogen atom from the 
OH group. 
 Phenolic acids and flavanoids also work as reducing agents, free radical 
scavengers and quenchers of single oxygen formation  (Ali Ghasemzadehet al 
2011) 
 Phenols and flavanoidsposses diverse biological activities, for example, anti 
ulcer, anti-inflammatory, anti-oxidant, cytotoxic and anti-tumor, anti-
spasmodic and anti-depressant activities. 
 Phenols are the most important groups of secondary metabolites and bioactive 
compounds. Hydroquinone is one of the phenolic group inhibits the free 
radical reactions. (CHO7Alchohol HTI). It is also an antioxidant substance 
capable of scavenging free superoxide radicals, anti-aging and reducing the 
risk of cancer. 
Carboxylic Acid 
 Benzene-poly-carboxylic Acid Complex (BP-CI) is a novel anticancer 
complex against human cancer cells. 
 Docosahexaenoic acid (DHA) is an omega-3 fatty acid. Its structure is a 
carboxylic acid (-oic acid) with a 22- carbon chain (docosa-is Greek for 22) 
and six (hexa-) cis double bounds 
[]
.  
 DHA was revealed to increase the efficacy of chemotherapy in prostate cancer 
cells and a chemo protective effect in a mouse model was reported.  
 It may also be used as a non- toxic adjuvant to increase the efficacy of 
chemotherapy. 
 In mice, DHA was found to reduce growth of human colon carcinoma cells 
The cytotoxic effect of DHA was caused by decrease in cell growth 
regulators. 
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Ether: 
 Certain ether lipids such as 1-0-octadecyl-2-0 methyl-rec-glycero-3-
phosphocholine represent a new class of anti -neoplastic agents. These 
ether lipids have been shown to be cytotoxic for a wide variety of tumors. 
 
Alkyl halides : 
 High propotionof  low molecular weight alkyl halides may be weakly 
carcinogenic and provide evidence supporting and eletrophillic hypothesis of 
carcinogenesis
(101)
. 
 
SEM (Scanning electron microscope) 
The following image is done by 80000X  via 500nm aperture shows maximum depth 
focused. 
 
 
Fig.No.20. Showing nano particles in SEM image of 500nm 
The particle size ranging from 80nm-120nm 
 
Interpretation 
 Nanoparticles, according to the American Society for Testing and Materials 
(ASTM) standard definition, are particles with lengths that range from 1 to 
100 nm in two or three dimensions. 
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Advantages of nano particles 
 
 Enhancing solubility of hydrophobic drugs, 
  Prolonging circulation time, 
 Preventing undesirable side effects, 
 Minimizing nonspecific uptake, 
 
 
 Specific cancer targeting(102). 
 Improvingintra cellular penetration, 
 The test drug Rasaparpam contains nanoparticle 
 Nano particles present in the drug results in a better bioavailability and 
facilitates absorption. 
 
 Nanotechnology a promising way from cancer management towards cancer 
elimination. 
 The particles of nano size show that the drug may easily enter the cells at the 
molecular level to treat the disease rapidly and increase the therapeutic effect. 
 
ICP-OES Results and Interpretation 
Table No.14.ICP-OES Resultsof  RP 
 
 
 
 
 
 
 
 
 
 
S.No Elements Detected levels 
1 Aluminium BDL 
2 Arsenic BDL 
3 Cadmium BDL 
4 Copper BDL 
5 Mercury 13.879mg/L 
6 Potassium 03.821 mg/L 
7 Sodium 04.300 mg/L 
8 Nickel BDL 
9 Lead BDL 
10 Sulfur 70.304 mg/L 
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Interpretation 
         From the above results, the heavy metals Arsenic, Cadmium and Lead were 
found below detection level. Mercury, Sodium and Potassium are observed within the 
permissible limits. 
Sulfur 
Sulphur is commonly used in Asia as an herbal medicine to treat inflammation 
and cancer.  
 Organic Sulfur has been studied on oral and other cancers and has been found 
to have remarkable benefit in anti-cancer therapy. 
 Hence the safety of the drug Rasaparpam is ensured. 
 
Raman Spectroscope – results of RP 
 
 
 
Fig.No:21.  Raman spectrometer peaks of RP. 
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Table No.15.  Raman Spectroscope – results of RP 
 
Frequency, cm
-1 
Functional group  Raman Bond  
3616.09 O-H Weak  
3097.39 =C-H Strong  
2200.71 C=C Strong  
940.01 C-O-C Medium  
814.89 C-O-C Medium  
371.57 (CC)Aliphatic chains Strong  
 
Interpretation 
 The drug obtained after sublimation process as per standard Siddha- SOP 
shows carbon linkages with Hydrogen, Carbon, Oxygen and aliphatic chains. 
 These bond natures might be Ionic, Covalant, coordinate covalent ( C-O-C 
bond linkage, C=C bond linkage) 
 The sublimation process convert the heterogeneous material into 
homogeneous substance and creating new complex compounds of various 
bonds. 
 Electronegativity is a measure of the tendency of an atom to attract a bonding 
pair of electrons.  
 The bonding pair of electrons of one atom is pulled towards the other end of 
the atom bond. 
 The larger the difference in electro negativity between the two atoms involved 
in the bond, makes it more ionic. 
 This electronegativity/nucleophillic property of the Rasa parpam makes free 
radicals to get attracted by this electron clouds and some of the new bonding 
make hold the metabolites from damaging the cells and detoxify them and also 
these characters favours the phenomenon of electron transport chain and 
maintain the cellular metabolism properlyand ensures the Anti-Oxidant 
property. 
 Essential propertiesof anti-oxidants:Oxidative stress induced cell damage 
through damage to proteins, lipids and DNA. It may also alter signaling 
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pathways redox sensitive to changes involved in the response of apoptosis. 
The antioxidants are currently the subject of many studies because, in addition 
to some interest in the preservation of comestibles, they could be useful in the 
prophylaxis and treatment of diseases in which oxidative stress is implicated. 
 From the present study, it was concluded that the Rasaparpam extract has 
good anti-oxidant activity at higher concentrations. 
 So, theRasaparpam due to its anti-oxidant property could  eliminate cancer 
cells.  
 
ACUTE ORAL TOXICITY 
Dose finding experiment  and its behavioral signs of Toxicity for Rasaparpam. 
Observation done  
Table No.16. Observational study 
 
S.No Group Day 
1 Body weight Slightly decreased 
2 Assesments of posture Normal  
3 Signs of convulsion 
 Limb paralysis  
No signs of convulsion and 
paralysis 
4 Body tone Normal  
5 Lacrimation  Slightly increased  
6 Salivation  Normal  
7 Change in skin colour Normal  
8 Piloerection  Abnormal  
9 Defection  Normal  
10 Sensitivity response Normal  
11 Locomotion    Normal  
12 Muscle gripe Normal  
13 Rearing  Normal  
14 Urinatiom Normal  
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Table  No.17. Observational study Results 
 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
 
RP 
200 
mg/kg 
 
+ - + - - + - - - - - - - - + - - - - - 
 
1.Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5.Gripping  6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9.Convulsions 10. Muscle Spasm 
11.Catatonia 12.Muscle relaxant 13. Hypnosis 14.Analgesia 15.Lacrimation 
16.Exophthalmos 17.Diarrhea 18.Writhing 19.Respiration 20.Mortality. 
(+ Present, - Absent ) 
Table No.18.Body weight observation 
 
 
 
 
 
Acute toxicity Discussion 
 In the acute toxicity study, the rats were treated with different concentration of 
Rasa Parpamfrom the range of 5mg/kg to 200mg/kg. 
 This dose level did not produce signs of toxicity, behavioral changes and 
mortality in the test groups as compared to the controls when observed during 
14 days of the acute toxicity experimental period. 
 These results showed that a single oral dose of the extract showed no mortality 
of these rats even under higher dosage levels indicating the high margin of 
safety of this extract. 
 In acute toxicity test Rasaparpamwas found to be non toxic at the dose level 
of 200mg/ kg body weight. 
DOSE 
 
DAYS 
1 7 14 
CONTROL 180.6±1.44 181.4 ± 4.32 183.2 ± 7.63 
HIGH DOSE 190.5± 7.75 188.7 ± 1.67
ns 184.4 ± 2.67ns 
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28 days Repeated  Oral Toxicity of Rasaparpam 
Table No.19.Body weight of wistar albino rats group exposed to RP 
 
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test) 
 
Table No.20. Haematological parameters of Wistar albino rats group exposed to 
RP 
 
Category Control Low dose Mid dose High dose 
Haemoglobin(g/dl) 13.8±0.88 13.90±1.16 11.14±0.66 9.28±1.16
* 
Total WBC (×10
3   
l) 11.91±0.59 11.85±1.23 10.08±1.21 8.110±2.27
* 
Neutrophils(%) 33.65±0.06 33.3±1.24 32.11±2.16 30.20±1.10 
lymphocyte (%) 70.24±1.48 70.02±1.12 69.20±1.16 60±1.26
* 
Monocyte (%) 0.86±0.07 0.85±0.19 0.72±0.13 0.71±0.60 
Eosinophil(%) 0.54±0.09 0.54±0.12 0.62±0.16 0.72±0.04 
Platelets cells10
3
/µl 687.17±8.76 678.71±9.16 623.18±2.20 627.16±3.74 
Total RBC 10
6
/µl 7.99±0.12 7.79±1.57 7.62±0.19 6.05±0.12
* 
PCV% 37.79±0.6 37.35±1.23 32.98±1.18 25.82±2.14
* 
MCHC g/dL 33.6±2.23 33.29±1.19 30.18±1.12 34.03±1.14 
MCV fL(µm
3
) 49.07±3.64 47.28±8.12 45.20±1.24 4.22±1.94 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 180.6±3.62 181.4 ± 4.14 183.7 ± 9.61 184.6 ± 3.03 185.7 ± 1.31 
LOW DOSE 183.2 ± 1.14 181.4 ± 2.12 179.6±2.36 177.2 ± 4.78
* 174.12± 2.39** 
MID DOSE 186.6± 1.64 181.3 ± 2.74 179.4 ± 8.32 174.1 ± 3.16
* 172.7 ± 3.82** 
HIGH DOSE 184.4± 6.74 179.7 ± 3.64 176.4 ± 1.51 170.1 ± 4.66* 164.4± 3.76
** 
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Table No.21. Biochemical Parameters of Wistar albino rats group exposed to 
Rasa Parpam 
 
BIOCHEMICAL 
PARAMETERS 
CONTROL 
LOW 
DOSE 
MID DOSE HIGH DOSE 
GLUCOSE (R) (mg/dl) 74.45±13.4 78.16±1.24 92.26±1.22 110.12±9.60 
T.CHOLOSTEROL(mg/dl) 115.26±1.83 118.45±1.13 132.42±1.78 156.22±1.93 
TRIGLY(mg/dl) 46.35±1.48 48.22±1.28 49.58±1.80 59.66±1.13* 
LDL 73.8±2.43 75.24±3.14 82.14±1.24 96.64±4.12
* 
VLDL 15.2±2.44 15.82±1.14 18.44±2.14 19.24±4.16 
HDL 26.66±6.88 26.16±1.24 24.68±2.16 20.78±1.12
* 
Albumin(g/dL) 
3.3±0.17 3.23±0.22 2.48±2.02 
2.14±3.16* 
  
NS- Not Significant,**(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
Table No.22.Renal function test of Wistar albino rats group exposed to RP 
 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
UREA (mg/dl) 13.35±0.99 14.81±1.26 16.26±1.18 21.28±3.12
* 
CREATININE(mg/dl) 0.58±0.08 0.48±0.06 0.72±0.14 0.94±0.12
* 
BUN(mg/dL) 15.12±0.10 15.12±0.28 16.28±0.14 16.90±1.22 
URIC ACID(mg/dl) 5.37±0.35 5.11±0.43 6.72±2.15 7.28±0.14
* 
 
 NS- Not Significant, **(p > 0.01), * (p >0.05) , n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
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Table No.23.Liver Function Test ofWistar albino rats group exposed to Rasa 
Parpam 
 
PARAMETERS CONTROL LOW DOSE MID DOSE 
HIGH 
DOSE 
T BILIRUBIN(mg/dl). 0.50±0.07 0.58±0.16 0.62±0.18 0.76±0.15
* 
SGOT/AST(U/L) 114.95±1.39 118.15±2.11 131.21±1.23 145.55±1.23
* 
SGPT/ALT(U/L) 71.23±1.28 76.91±1.59 82.34±2.18
* 86.32±1.28* 
ALP(U/L) 146.25±8.77 144.2±6.27 149.16±4.17* 153.3±4.25* 
T.PROTEIN(g/dL) 6.32±0.38 6.12±1.34 5.76±0.23
* 5.10±1.26* 
 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
 
Interpretation 
 The dose selected for the sub acute toxicity study was 20mg, 40mg/kg of 
Rasaparpam. 
 All the animals were free of intoxicating signs throughout the dosing period of 
28 days. 
 No physical changes were observed throughout the dosing period. 
 Mild toxic but no mortality was observed during the whole experiment. No 
abnormal deviations were observed. 
 No significant changes were observed in the values of different parameters 
studied when compared with controls and values obtained were within normal 
biological and laboratory limits. 
 The weights of organs recorded that shows mild differences in the treatment 
when compared to control group. This indicates that 
NamachivayaChendooraminduce mild changes in liver and kidney but not 
toxic to rest ofthe organs. 
 There was slight changes were observed in hemoglobin (Hb), red blood cell 
(RBC). No significant changes in white blood cell (WBC), packed cell volume 
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(PCV), Erythrocyte sedimentation rate (ESR) in all the treated groups as 
compared to respective control groups. 
Histopathology Examination  
 
 Histopathology studies were carried out on liver, kidney and spleen were 
recorded. Blood samples for haemotological and bio chemical analysis were 
taken from common carotid artery. 
 All tissues were preserved in 10% neutral buffered fomaldehyde solution for 
histopathological examination. The internal organs and tissues were observed 
for gross lesions. 
 
PHARMACOLOGICAL STUDY 
 
Table No.24. Anticancer effect of Rasaparpamon HeLa cell line 
 
S.No. Concentration 
(µg/ml) 
Dilutions Absorbance 
(O.D) 
Cell viability 
(%) 
1 1000 Neat 0.495 34.13 
2 500 1:1 0.595 41.03 
3 250 1:2 0.672 46.34 
4 125 1:4 0.781 53.86 
5 62.5 1:8 0.887 61.17 
6 31.2 1:16 1.008 69.51 
7 15.6 1:32 1.105 76.20 
8 7.8 1:64 1.219 84.06 
9 Cell control - 1.450 100 
 
 The percentage of growth inhibition was found to be increasing with 
increasing concentrations of test drug . The IC50 of test sample in HeLa cell 
line was found to be 125 µg/ml. This confirms that the Siddha formulation 
Rasaparpamhas promising anti-cancerous effect. 
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Graph 1  
Graph-1 shows the drug dose and % of Inhibition of HeLa cells after theRasa 
parpam extract treatment. It can be observed by the result of MTT assay that the IC dose 
of Rasa parpam is 125µg/ml. As the dose increases the HeLa cell viability decreases. It 
was found that the % growth inhibition increasing with increasing concentration of 
Rasaparpam steadily up to 7.8 µg/ml on HeLa cell line (Table No: (24) and Graph(1) and 
that  IC value on HeLa cell line was 50 and R value was 1.450. 
Interpretation  
Cytotoxic effect by MTT assay: 
 MTT ia a yellow water soluble tetrazolium salt. Succinate dehydrogenase , a 
mitochondrial enzyme  in living cells, cleaves the tetrazolium ring, converting 
the MTT to an insoluble purple formazan. Therefore, the amount of formazan 
produced is directly proportional  to the number of viable cells. 
 This assay is based on the metabolic reduction of 3- (4,5-dimethylthiazol-2-yl) 
-2,5-difeniltetrazol (MTT) by mitochondrial enzyme succinate dehydrogenase 
in a coloured compound blue (formazan), allowing to determine the 
functionality of the mitochondrial treated cells. This method has been widely 
used to measure survival and cell proliferation.  
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 The amount of living cells is proportional to the amount of formazan 
produced. Cell lines derived from NCCS, Pune were free from any kind of 
bacterial and fungal contamination. 
 To determine the cytotoxic effect of novel Siddha formulation Rasa parpam 
against HeLa cells. The experiment was screened at different concentrations to 
determine the IC50 using MTT assay. A chart was plotted using the % cell 
vibility in Y-axis and concentration of the test sample  in X-axis.   
 The percentage of growth inhibition was found to be increasing with 
increasing concentrations of test drug . The IC50 of test sample in HeLa cell 
line was found to be 125 µg/ml. This confirms that the Siddha formulation 
Rasaparpam has promising anti-cancerous effect.  
 RASA PARPAM at different doses (7.8-1000 µg/ml of 5% MEM)was 
administered for 24 hrs. It was found that the number of cells decreases as the 
dose increases and at approximately 125 µg/ml dose of extract, 50% of the 
cells (HeLa cells) were less as compared to normal control as shown in 
Fig.No:23.  
 The percentage of cells viability was determined by calculating the O.D of 
treated against thecontrol. 
  Reading optical density (OD) is performed in a spectrophotometer at a 
wavelength of 570 nm.Comparison values are made on a basis of 50% 
inhibition of growth (IC50) in treated cells with specific agents.Results are 
tabulated in Table (24) and graphically represented in Graph(1). 
Analysis  of  Membrane  Morphological  Characteristics  by  Haematoxylin  /Eosin 
 
(H/E) Staining 
 
 Morphological changes such as changes to the cell membrane, loss of 
membrane asymmetry and cell shrinkage, are the early stage of apoptosis was 
analyzed by H/E staining.  
 The IC dose (125µg/ml) treated cancer cells show features of apoptosis 
whereas treated with same amount of dose, to normal treated cells appeared 
without any significant changes.  
 Since the discovery of the Cisplatin anti-tumor activity, great efforts have 
focused on the rational design of metal-based anticancer agents that can be 
potentially used in cancer chemotherapy.  
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 Over the last four decades, a large number of metal complexes have been 
extensively investigated and evaluated in- vitro and in- vivo.
(103)
 
 
 The key focuses of these studies lie in finding novel metal complexes which 
could potentially overcome the hurdles of current clinical drugs including 
toxicity, resistance and other pharmacological deficiencies. 
 Metals and metalic compounds have been used in medicine for several 
thousands of years. The medicinal uses and applications of metals and metal 
complexes are of increasing clinical and commercial importance.  
 Monographs and major reviews, as well as dedicated volumes, testify to the 
growing importance of the discipline
(104)(105)
. 
 Relevant reviews are to be found throughout annual series, for example Metal 
Ions in Biological Systems 
(106)
. 
 The field of inorganic chemistry in medicine may usefully be divided into two 
main categories: firstly, ligands as drugs which target metal ions in some form, 
whether free or protein-bound and secondly, metal-based drugs and imaging 
agents where the central metal ion is usually the key feature of the mechanism 
of action 
(107)
.   
 Arsenic has been used therapeutically for more than 2,000 years and was used 
in the 1930s for treatment of chronic myeloid leukemia until supplemented by 
newer chemotherapies 
(108)
. 
 Side effects are cardiotoxicity, skin rashes, and hyperglycemia(109). 
 Oncologists and scientists engaged in the research of cancer treatments should 
conduct a comprehensive study on the efficacy of Mercury which is being 
used as an anti-cancer drug in the age old Siddha system.  
 Three years of research has shown that metal (Mercury, Arsenic and Copper) 
based Siddha drug is a safe alternative for Cisplatin therapy or Arsenic 
trioxide in selected cases of cancer treatments wherein the patients cannot bear 
the adverse effects.  
 He found that mice treated with Siddha drugs showed better health than what 
did in Cisplatin therapy in terms of appetite, haemoglobin, red blood cells and 
white blood cells
(110)
. 
 
 
RESULTS AND DISCUSSION 
 
ANTI CANCER ACTIVITY OF RASA PARPAM Page 120 
 
Anti-tumor activity 
Rasaparpam Induced HeLa and SiHa cell Apoptosis    
Cell Apoptosis 
Cell apoptosis was analyzed by flow cytometry based on the Annexin V-FITC/ 
propidium iodide apoptosis kit. Briefly, the HeLa cells and SiHa cells were treated by 
RP (1.25,2.5 and 5.0µg/ml) then collected and washed twice by ice-cold PBS. After 
that, the cells were stained with Annexin V-FITC / propidium iodide. Apoptosis was 
evaluated by a flow cytometry assay. 
 
Interpretation 
 
 In this study, Annexin V/PI binding was used to evaluate the apoptosis of the 
cancer cells induced by RP. As shown in Figure , the percentage of apoptotic 
cells were significantly increased from 3.92% ± 2.09% to 22.86% ± 3.01%, 
23.68% ± 4.5% and 66.03% ± 4.51% after the HeLa cells were treated with 
RP (1.25,2.5 and 5.0µg/ml) for 12 h. 
 In addition, the percentages of apoptotic cells were significantly increased 
from 10.33% ± 6.39% to 38.92% ± 12.39%, 47.13% ± 13.61% and 56.99% ± 
14.24% after the SiHa cells treated with RP (1.25,2.5 and 5.0µg/ml) for 24 h.  
 
All these  above data indicated that RP altered the growth kinetics of  HeLa and SiHa 
cells in a significant manner that could be a positive indicator for testing its anti-tumor 
activity in cervical cancer cell. 
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Anti-Oxidant activity Activity 
Table No.25. DPPH Assay of Rasaparpam 
Concentration  
(µg/ml) 
Absorbance  
 
Percentage of  
Inhibition  
Rasaparpam Drug  Standard Drug  Standard 
Control  0.5432 0.327 - - 
1.25 0.4876 0.235 10.23 28.14 
2.50 0.4327 0.168 20.34 48.63 
5.00 0.3527 0.114 35.07 65.14
** 
10 0.2653 0.097 51.16* 70.34 
20 0.1317 0.067 75.75 79.52 
 
(µg/ml) microgram per mililiter.Drug:RP (1.25µg/ml-20µg/ml) Standard: Ascarbic 
acid(10mg/mlDMSO) 
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DPPH stable free radical method is an easy, rapid and sensitive way to 
survey the antioxidant activity of Rasaparpam extract. The antioxidant molecules 
can quench DPPH free radicals by providing hydrogen atom or by electron 
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donation and a colorless stable molecule 1, 1 diphenyl-2-picryl hydrazyl is formed 
and as a result to which the absorbance at 517 nm of the solution is decreased.  
In the present study the Rasaparpam extract was analyzed was able to 
decolorize DPPH and the free radical scavenging activit y was expressed as the 
percentage decrease in absorbance. 
(10mg/mlDMSO) have a concentration-dependent anti-radical activity which was 
tabulated in Table No.25 
A maximum of 75.75% and 79.52 % anti-radical effects are exercised by 
Rasaparpam and standard drug ascorbic acid at concentrations of 20 µg / ml 
respectively. Minimum percentage of inhibition 10.23% and 28.14% anti-radical 
effects are manifested by Rasaparpam and standard drug ascorbic acid at 
concentrations at 1.25µg/ml.  
This indicated that % of inhibition increased with increase in concentration of 
both the standard and Rasaparpam extract. But the Rasaparpam extract has lower 
DPPHscavenging activity than that of standard. From the present study, it was 
concluded that the Rasaparpam extract has good anti-oxidant activity at higher 
concentrations. 
It is known that oxidative stress induced cell damage not only through damage 
to proteins, lipids and DNA. It may also alter signaling pathways redox sensitive to 
changes involved in the response of apoptosis. The antioxidants are currently the 
subject of many studies because, in addition to some interest in the preservation of 
comestibles, they could be useful in the prophylaxis and treatment of diseases in 
which oxidative stress is implicated. Many studies realized on natural products have 
proven that they are especially phenolic compounds who are responsible for their 
antioxidant activity. 
Several studies have shown the link between the traditional drug formulations 
rich in anti-oxidants and the incidence certain diseases such as cancer, diabetes, heart 
disease and other diseases related to aging. Phenolic compounds could prevent cancer 
by the action antioxidant and the modulation of several functions of proteins. Phenolic 
compounds can prevent carcinogenesis by affecting the molecular events in the 
triggering, promotion and progression stages. 
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Here, the reactive oxygen species (ROS) may be the triggers apoptotic process. In 
recent years  numerous properties have been described about these compounds such 
as the ability to inhibit cell cycle, proliferation cellular and oxidative stress and induce 
detoxification enzymes, apoptosis  and stimulate the immune system. It is therefore 
hypothesized that Rasaparpam of its anti-oxidant power could  eliminate cancer cells. 
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                                 Fig.No.23. Anti-cancer activity of Rasaparpam. 
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     6. CONCLUSION 
 
Cervical cancer is the second most common malignancy found among women 
worldwide and some are highly resistant to radiotherapy. The other chemotherapy 
drugs causses intolerable side effects which are worse than the disease. This paved way 
for a novel anticancer drug which cures cervical cancer in a non invasive method. 
 The intention of this study is to provide a solution for the above need for a non 
violent anticancer drug to cervical cancer. Rasa Parpam was chosen as a trial 
drug from the Siddha literature  “Aathma Raksha Mirtham Ennum Vaithiya 
Saara Sangiragam” written by Kandhasamy Mudhaliyar which was 
categorized by the department of AYUSH as a classical text. Throughout the 
study, the safety and efficacy were tested thoroughly. 
 The procedure for drug preparation and its techniques for standardization 
revealed GMP. The trial drug RSP has satisfied all parameters of testing 
protocol for Parpam which was assigned by AYUSH. It showed the accurate 
production and potency of Rasaparpam. 
 Physico-chemical analysis revealed better bio-availability and richness of its 
mineral content. Favouring this study were the presence of inorganic matters 
which were found through experiments for analyzing acid and basic radicals. 
 Various instrumental analysis of Rasaparpam such as FT-IR spectroscopy, 
Raman spectroscopy and scanning electron microscope demonstrated its 
chemical constituents, functional groups and particle size to support its 
indication to counter cervical cancer. 
 The anti-microbial activity of trial drug was also considered for its potential 
  Under OECD guidelines, the acute and 28 days repeated oral toxicity studies 
proved the safety of Rasaparpam at particular dose level. It is very useful in 
therapeutic dose determination. 
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 The pharmacological activities are justified by anticancer effect on HeLa cell 
lines, anti-tumour effect on HeLa and SIHA cell lines and quantitative 
measurement of antioxidants by DPPH assay. 
 Factors like safety, efficacy, long self like, bio-availability, presence of 
significant elements, anions and cations and minerals favouring the activity 
justifies the main perspective of this study. 
 Anti-cancer effect could be validated scientifically. Due to its Non-toxic anti-
cancer effect, it would benefit the female community in the  world.
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7. SUMMARY 
 
Trial drug RASA PARPAM was selected from the classical Tamil literature 
“Aathma Raksha Mirtham Ennum Vaithiya Saara Sangiragam” written by 
Kandhasamy Mudhaliyar forits  anti-cancer activity. 
The dissertation was started with an introduction explaining about the Siddha 
concept, prevalence of cervical cancer and role of the test drug in treating cancer 
cervix. 
Review of literature in various categories was carried out. It was elaborated 
under Gunapadam and Modern aspect of ingredients, Siddha and modern aspect of 
that disease, pharmaceutical aspect and pharmacological aspect in both Siddha and 
modern. 
All the ingredients were identified and authenticated by experts. 
The compound was prepared properly by given procedure in an appropriate 
situation. The end product underwent standardization parameters in Siddha. 
The drug was subjected to analysis such as physiochemical, biochemical and 
instrumental which provided the key ingredients present in the drug thus it accounts  
forthe efficacy of the drug. 
The sample was also analysed for anti-microbial load to ensure its accuracy. 
For the study protocol, required animals were approved by the IAEC under 
CPCSEA. 
Toxicological study was made according to OECD guidelines comprising both 
acute and repeated oral dose 28days toxicity studies in wistar albino rats. It showed 
the safety of the drug which attributes its utility for long time administration. 
Pharmacological studies were completed. It proved the  
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Anti-cancer activity through HeLa cell line , anti-tumor activity through HeLa 
and SiHa cell line models  and anti-oxidant activity by DPPH assay of RASA 
PARPAM. 
Results and discussion gives the essential validations to prove the potency of 
the drug. 
Conclusion gives a compiled form of the study and explains the synergistic effect of 
all the key ingredients and activities that supports the study. 
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8. FUTURE SCOPE 
 
Trial drug for the study RASA PARPAM was taken from the classical Siddha 
literature Aathma Raksha Mirtham Ennum Vaithiya Saara Sangiragam, Written by 
Kandhasamy Mudhaliyar. 
Its validation for its Anti-cancer nature was completed at preliminary level. 
The result enhanced and assured its Anti-cancer property against cervical cancer.More 
specific experiments on animal models and also clinical trials are required to 
understand the exact molecular mechanisms of action. So it could be used worldwide 
in treatment of cervical cancer and satisfy the safe and painless anti-neo plastic 
treatment. 
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